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The preparation o f 1,10-phenanthroline derivatives entailed ring opening
reactions of 1,10-phenanthroline epoxide as a key transformation, affording novel
bidentate nitrogen ligands with new stereogenic centers in the 5- and 6-position. This
research was concerned with [i] the epoxidation o f 1,10-phen, [ii] epoxide ring opening
reactions,

[iii] the formation o f fr<my-5,6-disubstituted-1,10-phenanthroline metal

complexes, and [iv] application o f 1,10-phenanthroline derivatives in metal-catalyze
reactions such as palladium-catalyzed allylic substitution and aminohalogenation
reactions; Zinc-catalyzed direct aldol reaction, and acetophenone reduction; Nickelcatalyzed Michael addition reaction.
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CHAPTER 1: INTRODUCTION

The concept of “chirality” has been known in chemistry since the 1870’s although
it would be nearly a hundred years before chemists began using this term. In 1847 Louis
Pasteur resolved, for the first time, an enantiomeric pair of tartaric acid salts by
mechanical separation based on their difference in crystal shape. Pasteur recognized that
the two isomers rotated polarized light in opposite directions. Following Kekule’s
recognition in 1858 that carbon is tetravalent,1 van’t Hoff and Le Bel independently
recognized that when four different groups are attached to carbon, their arrangements can
be in two different orientations. Since then, chirality has been recognized as extremely
important not only in chemical or biological research, but also to life itself.

What is chirality? Chiral, derived from the Greek word ‘cheir ’ (hand), refers to
the way two otherwise identical molecules (Figure 1.1) can be non-superimposable
mirror images of each other just as our hands mirror each other. These molecules are
referred to as ‘enantiomers’ and can react differently with other chiral molecules, such as
enzymes. Ultimately, stereoisomers can display drastically different biological activities
(vide infra).

Figure 1.1 Two “chiral” forms (enantiomers)

1
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Many chiral compounds can be found in nature in enantiopure or enantioenriched
form. Examples include amino acids, carbohydrates, nucleic acids, and alkaloids. The
importance o f enantiomerically pure compounds comes from the central role o f
enantiomer recognition in biological processes. Noyori stated that “Life depends on chiral
recognition, because living systems interact with enantiomers in decisively different
manners. ” As a consequence often only one enantiomer o f a given drug has the desired
effect while the other one may even be harmful. The most well known dramatic example
is thalidomide. Its (S) enantiomer exhibits teratogenic activity and the (R) enantiomer
acts as a sedative. (Figure 1.2)

O Q

O O

O

O O

O

(S)-thalidomide

(R)-thalidomide
Mirror
plane

Figure 1.2 (S) and (R)-thalidomide enantiomers

Given the dramatic impact stereochemistry can have on biological activity there is
a strong need for enantioselective processes in drug development. Discussed further are
some o f the reasons why organic chemists have put forward tremendous efforts in the
field o f asymmetric synthesis during the last few decades. For drug delivery, the potency
o f an active enantiomer compared with a racemic mixture o f active and inactive
enantiomer is such that the dose may be reduced. Another reason for the preparation o f a

2
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single active stereoisomer is economics, increasing yields of specific enantiomers at low
cost and reducing the waste of starting materials and reagents on the inactive isomer.

Stereochemistry also plays an important role in food and agricultural chemistry.
Tastes and smells can vary with stereochemistry, for example (R) and (S)-limonene
enantiomers are found in oranges and lemons, respectively. Agrochemicals may be easier
or harder to degrade depending on which enantiomer of the chemical substance is used.
Due to the growing concern about environmental aspects in modem society this branch of
industry has an increasing need for enantioselective processes.

1.1 Towards Enantiomerically Pure or Enriched Compounds

There are three basic approaches to generate enantiomerically pure or enriched
compounds.
a) Resolution is the oldest process and is based on the synthesis of the racemic target
molecule or intermediate which is then resolved with the help of an enantiomerically pure
reagent. Resolution is still important and widely used today, but it has some drawbacks,
i.e. resolution is often expensive. Also a suitable resolving agent is required and the
unwanted enantiomer has to be disposed of. The drawback of the unwanted enantiomer
of the product can sometimes be overcome by recovering/recycling the isomer in a
dynamic kinetic resolution process as is done with 1-phenylethanol (Scheme 1.1).3 The
dimeric ruthenium complex 1 catalyzed hydride transfer and was employed in tandem
with Novozyme 435 (Candida Antarctica lipase B immobilized on resin) to achieve
dynamic kinetic resolution.

3
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OAc

OH

1, N o v o zy m e 4 3 5
p-C IC 6H4O A c

Ph

80%
e:r> 99.5:0.5

1-phenylethanol

Ph

? u.

? u- Ph
CO

oc cooc

Scheme 1.1 Resolution of 1-phenylethanol

b)

A “chiral pool ” approach refers to the synthesis of the target molecule based

on commercially available, enantiomerically pure starting materials that contain one or
more stereogenic centers. Unfortunately, this method is limited by the availability of
suitable starting materials. Costs may also be a problem since unnatural enantiomers,
which are man-made, are usually more expensive. A classic example of the “chiral pool”
approach is shown in Scheme 1.2; the Stork synthesis of prostaglandin A 24 starts with the
acetonide derived from L-erythrose.

PGA2

L -erythrose

Scheme 1.2 Chiral synthesis of Prostaglandin A2 starting with
commercially available L-erythrose

4
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c)

Asymmetric synthesis involves a prochiral substrate that is converted into an

enantiomerically pure product in a reaction mediated by a chiral reagent, auxiliary or
catalyst, either in stoichiometric or catalytic fashion. Also “asymmetric synthesis” has
contributed by making available chiral starting materials to expand the “chiral pool”.5
This enables synthetic chemists to prepare target molecules from chiral starting materials
that are unavailable from nature. Due to its importance, asymmetric synthesis and in
particular “asymmetric catalysis’’’ are discussed in more detail in the following sections.

1.2 Asymmetric Synthesis - Ligands and Metals

Asymmetric synthesis can also be carried out with the help of chiral reagents 6
which involves the use of at least one equivalent of enantiopure material, as seen for the
asymmetric reduction of prochiral ketone with a chiral hydride reagent7 (Scheme 1.3).
Me

i

N

90%, 100 % ee (S)

Scheme 1.3 Reduction of 2-cyclohexen-l-one

Because the chiral reagent is usually the most expensive component, a lot of effort
has been spent on developing catalytic methods (asymmetric catalysis). When a chiral
catalyst is involved, its substoichiometric amount can produce a large amount of
enantiomerically enriched or enantiomerically pure product. The catalyst increases the
rate of a chemical transformation without itself being consumed. Asymmetric catalysis
5

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

can provide a powerful solution to access chiral materials, which are not readily available
otherwise. For example, optically active terminal epoxides are not available from nature’s
“chiral pool”, which can now be readily prepared in one step from the corresponding
racemates

by

using

the

salen

[(7?,i?)-A/,jV’-bis(3,5-di-fcr/-butylsalicyldene-l ,2-

cyclohexane-diaminato(2-)] cobalt (II), catalyzed hydrolytic kinetic resolution (salen =
[(i?,7?)-A(./V’-bis(3,5-di-terf-butylsalicyldene-l,2-cyclohexane-diaminato(2-)].8

Most

asymmetric catalysts consist of metal complexes attached to chiral ligands. Metals are
known to be extremely efficient catalysts for a wide variety of organic transformations,
usually offering high selectivity under mild reaction conditions. One early example of
metal catalyzed transformation is the osmium tetraoxide dihydroxylation of olefins using
N-methylmorpholine N-oxide (NMO), as co-oxidant.9 (Scheme 1.4)
OH
K

- g * 0 s0 < .

R4 y R

lequiv. NMO

*
0H
(rac)-diol

.

olefin

Scheme 1.4 Catalytic dihydroxylation of olefins

There is no universal chiral ligand or catalyst for solving all problems in
stereoselective transformations. Changing the chiral ligand will affect the reactivity and
selectivity of the metal center.10 The preparation of new ligands is perhaps the most
important step in the development of metal complexes, which exhibit unique properties
and novel reactivity. To develop new chiral ligands, a structural template needs to be
designed. Consideration of steric, electronic, and conformational properties is necessary

6
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to prepare an effective ligand because they affect metal coordination and thus catalytic
activity.

It should be mentioned that the improvement of an existing asymmetric version
process is usually a difficult goal to achieve. The improvement may require many years
of research before the process can become synthetically useful. An example of this is the
asymmetric dihydroxylation of olefins in the presence of A,A-dialkyl bispiperazines as
chiral ligands (Scheme 1.5).11 Bispiperazines 2 showed great compared to the preceding
ligand.
Ph
Ph

OH
1) 0 s 0 4 , chiral ligand 2
2) N a H S 0 3

H' f v Ph
Ph' T '*

OH
1,2-diphenylethane-1,2-diol

(E )-1,2-diphenyleth en e

81%, 98% ee
Ph

Ph

Ph

R1- N ^ N - R 2
P r '- N

N

(CH2)2— N

N—

Ph

\
Ph

1 a : R 1 = H, R2 = CH 3

2

N —'Pr

/
ph

1 b : R 1 = R2 = CH 3
m onocyclic pip erazin es
(the preceding ligands)

Scheme 1.5 Dihydroxylation of olefins using A,A'-dialkylbispiperazines

1.3 Our Hypothesis - Application of 1 , 1 0 - P h e n a n t h r o l i n e Derivatives as Chiral
Ligands

Our hypothesis is that the high rigidity of phenanthroline-type ligands improves
their catalytic performance. While most literature reports utilize type I and II templates,
we intend to study and optimize type III ligands (Figure 1.3).

7
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1,10-phenanthroline

|a

|jj

||

m

Figure 1.3 1,10-phenanthroline and chiral phenanthroline templates

Phenanthroline ligands and their many complexes find wide application in
chemistry.12' 16 The coordination chemistry of 1,10-phenanthroline was discovered in the
late nineteenth century.17 The rigid framework of phenanthroline has given it a superb
ability to coordinate with a large number of transition metals. Compared to the more
common 2,2’-bipyridine system, 1,10-phenanthroline can form complexes with metal
ions more rapidly.18 The metal-chelating properties of the phenanthroline and its
derivatives have been utilized in a range of analytical chemistry such as colorimetric
1Q

indicators for transition-metal ions, ’

Ifi

0 1

as ion-selective electrochemical sensors, ’

OO

as

18 26
fluorometric sensors, 23 ' 25 as well as for the development of bio-organic probes.
’

The bidentate 1,10-phenanthroline template is a strong chelating agent for a
variety of transition metals. Therefore, phenanthroline-metal complexes have become
attractive templates for which a ligated metal ion can serve as a Lewis acid binding site
and catalyst.27'30 Generally, nitrogen-containing chiral ligands have found wide use in
asymmetric catalysis. However, only a few chiral phenanthroline ligands are known.
Gladiali et al., in 1986, reported the first optically active 3-substituted phenanthrolines
which were used with rhodium for the preparation of chiral secondary alcohols from pro
chiral ketones (Scheme 1.6).31 In comparison with bipyridines, phenanthrolines have

8
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formed more reactive catalyst and shown higher enantioselectivities.29,30 This supports
the hypothesis that the higher rigidity in phenanthroline derivatives stabilizes favorable
metal-complexes and translates their chiral information better during catalysis.

O
II

[Rh(Diol)CI]2
ligand,* 2 -propanol

OH

PtfXHs

P IT
CH 3 "
a c e to p h e n o n e

1-phenylethanol

Scheme 1.6 Reduction of acetophenone using 3-substituted phenanthrolines

Later,

Gladiali

and

other

researchers

have

reported

additional

chiral

phenanthroline derivatives which can be grouped into two categories: (I), the chiral
auxiliary is connected to phenanthroline at either the 2- or 3-position or (II), the auxiliary
is fused to phenanthroline at the 2,3- and 8,9- position (Figure 1.3).32,33 The chiral
domains, when integrated into coordination complexes, may impart stereoselective
control to catalytic and molecular recognition processes.

Nevertheless, the ligand system, in which the chiral auxiliary is linked at the fi
ring of phenanthroline, is almost unprecedented. In one early work, Chelucci and co
workers synthesized the (R)-5,6-dihydro-5-methyl-l,10-phenanthroline as a heterocyclic
ligand (Figure 1.4).34 However, the lengthy synthesis (13 steps) limits the ligand’s
availability and its catalytic activity has not been tested.

9
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Figure 1.4 (7?)-5,6-dihydro-5-methyI-1,10-phenanthroline and our ligand
template with R attached to the B-ring
The objectives of this research are to synthesize 5,6-dihydro-1,10-phenanthroline
derivatives with chiral centers in the C(5) and C(6) position, and study how
stereoselectivity is affected by substituents in the 5- and 6- position during catalytic
reactions.

The change in hybridization in the 5- and 6- positions from sp (totally planar
1,10-phenanthroline) to sp3 causes a twist o f the bipyridyl unit, which changes the NCCN
dihedral angle (Figure 1.5). By doing so, the steric and/or electronic properties of B-ring
substituents can affect metal coordination.

X
//

\
:N

y

\
N =/

A ddition t ^

^
—N

Y
f/

^

M etal coo rd in atio n _

Ni

ls!—

Figure 1.5 Design of 1,10-phenanthroline template

My work on this research project included the synthesis of new enantiopure 1,10phenanthroline derivatives from 1,10-phenanthroline as starting material, characterization
and study of ligand properties toward transition metals, application of the ligand-metal
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complexes to transition metal-catalyzed reactions, and learning about asymmetric
induction effects as well as the behavior of 1,10-phenanthroline derivatives in
asymmetric catalysis.
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CHAPTER 2: EPOXIDATION

Epoxides are an essential and versatile class of organic compounds. The
chemistry of epoxides is particularly attractive since various other functional groups can
easily be prepared from them 1 such as alcohols, diols, amino alcohols and others.

In order to introduce chiral centers in the C5 and C 6 positions of phenanthroline,
the 5,6 -dihydro-1,10-phenanthroline epoxide is used as key intermediate in our project.
This epoxide can be prepared by oxidation of 1,10-phenanthroline with a suitable
oxidizing agent. More traditionally, epoxides are synthesized by the reaction of olefins
with hydrogen peroxide in the presence of acetic or formic acid .2 ,3 This convenient
method involves the in situ formation of the corresponding peracid, which serves as the
oxidizing agent. However, a downside of this method is potential side reactions of the
acid. An example of this is the use of peracid or hydrogen peroxide as oxidant in the
oxidation of 1 , 1 0 -phenanthroline resulting in the formation of a 1 , 1 0 -phenanthroline-Aoxide derivative (Scheme 2.1) . 4

m-CPBA

O'

80°C

-N

-70°C
'OH
1

, 1 0 -phenanthroline

Scheme 2.1 Side reactions during oxidation of 1,10-phenanthroline
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A cheap and practical alternative oxidant is aqueous sodium hypochlorite (bleach,
NaOCl), which can be used for epoxidation of 1,10-phenanthroline. The synthesis of
1,10-phenathroline epoxide was published in several articles.4 "6 In these reactions, NaOCl
was effectively applied as a cheap and convenient chlorine source in the presence of
tetrabutylammonium hydrogen sulfate as phase transfer catalyst (PTC, Scheme 2.2).

NaOCl (commercial bleach)

________pH 8.6_________
Bu4N+HS04-/CHCI3
1,10-Phenanthroline

1,10-phenanthroline-5,6 -epoxide

Scheme 2.2 Epoxidation of 1,10-phenanthroline with NaOCl

The PTC plays an essential role in aqueous-organic two-phase reactions and
ensures the transport of inorganic ions into the organic phase. It was also reported that
reaction rates for oxidations “become extremely fast provided that the pH of the aqueous
NaOCl is lower from 12.7 to about 9.5 ”

.7

The B-ring double bond between carbon 5 and

6

of 1,10-phenanthroline is the

most reactive site due to the principal canonical forms of aromaticity (Fig. 2.1) . 8 There
are four of five forms with a 5,6 double-bond, and this bond fixation becomes readily
attacked by many reagents. 9 , 10
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Figure 2.1 Canonical forms of 1,10-phenanthroline

Based on the electrophilic mechanism published by Antkowiak et al.,A the Cl+
cation adds to form a 5,6-chloronium intermediate that hydrolyzes to yield the
chlorohydrine. The course of the reaction is pH dependent. Under basic conditions
(ph>7), chlorohydrine eliminates hydrogen chloride to form the corresponding epoxide,
whereas

5,5-dichloro-6-oxo-l,10-phenanthroline

and

5,6-dioxo-5,6dihydro-l,10-

phenanthroline are formed as products of further oxidation, chlorination, and hydrolysis
reactions under acidic conditions (pH<7, Scheme 2.3).

NaOCl

1

chloronium
intermediate

, 1 0 -phenanthroline

5,6-diketone

5

chlorohydrine

5-dichloro-6-oxo
by-product

phen-epoxide

dichloro
by-product

Scheme 2.3 Oxidation pathways of 1,10-phenanthroline at different pH values
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We attempted to prepare 1,10-phenanthroline epoxide using various literature
procedures, 4 ' 6 however, we were unable to reproduce their results. The epoxidation
reaction consumed a large amount of oxidant reagent (industrial bleach), and time to
complete (12- 24 hrs). The ratio of epoxide product to by-products varied with different
pH values (8.0-9.5). We tested different bleach (4-13% chlorine concentration, in NaOCl)
at different pH between 8.0-9.5 which still did not improve the significantly.

Eventually, we modified the method of Lopez at el.,n and successfully prepared
high quality 1,10-phenanthroline epoxide in good yield (70-85%) and less time. 1,10Phenanthroline epoxide can be obtained by oxidation of 1,10-phenanthroline
monohydrate with bleach at pH

8 .6

under biphasic (CHCfi/aqueous) conditions while

using tetrabutylammonium hydrogen sulfate as phase transfer catalyst. Under our
conditions, we used commercial bleach

(~ 6

%) instead of more concentrated solutions

(industrial bleach) from Aldrich, which made the reaction less expensive to run. Also, we
did not use hydrochloric acid (HC1) to adjust the bleach’s pH to avoid the formation of
side products (5,6-dichloro and 5,6-chlorhydrin-l,10- phenanthroline). To improve the
quality and yield of phenanthroline epoxide, sulfuric acid (6 N H 2 SO4 ) was employed,
which reduces the Cl' concentration that promotes the formation of byproducts.
Moreover, 0.5 eq. of PTC provided the best results affording 1,10-phenanthroline
epoxide in a short time and good quality. The bleach’s quality decreased with time due to
self-decomposition (Equation 2.1) , 12 which accelerated at decreasing pH values. At the
end of the reaction a pH of -5.0 was typically observed. Because the quality of bleach
changed during the reaction time (15 to 30 min.) the yield decreased over time due to side
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product formation. 13 Moreover, the epoxidation reaction can be monitored by reverse
phase TLC, using MeOH/water (2:1 volume ratio).

3NaOCl -> 2NaCl + NaC103
Equation 2.1 Self-decomposition of bleach
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CHAPTER 3: RING OPENING REACTIONS-PREPARATION OF CHIRAL 5,6TRANS- DISUBSTITUTED PHENANTHROLINE DERIVATIVES

Chiral 5,6 -dihydro-1,10-phenanthroline derivatives are synthesized by the ring
opening reaction of 1 , 1 0 -phenanthroline epoxide with different amine nucleophiles to
functionalize the ligand template. The formation of ensuing amino alcohols proceeds in
an anti-fashion.

3.1 Epoxide Ring Opening

The ring opening of l,10-phenanthroline-5,6 -epoxide was previously reported by
Moody et al.,x in the preparation of Ascididemin, a natural marine alkaloid, with
anticancer properties. They tested various anilines, which were pre-adsorbed on basic
alumina, to give the corresponding chiral, racemic aminoalcohol derivatives (Equation
3.1). However, this method could not be extended to the ort/2 0 -substituted nucleophiles
such as 2-cyano and 2-haloanilines. According to the authors, steric congestion on the
alumina reaction surface could be a reason for limitation of this method.

p h en -ep o x id e
am inoalcohol x
d erivatives

Equation 3.1 Conversion of epoxide into aminoalcohol derivatives
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The pioneering work of Posner has shown that epoxides could be opened under
mild conditions using neutral and basic alumina with a variety of nucleophiles, such as
alcohols, thiols, and amines (Equation 3.2) . 2 ' 4 He also proposed that alumina catalyzes
this reaction by lowering the activation entropy of the epoxide and nucleophile adsorbed
close to each other and in the proper orientation for Alumina probably activates the
nucleophile by having the Al-O-Al ring on alumina to cleave the heteroatom-H bonds of
alcohol, primary and secondary amines. 3

row

_

Et20 , 25 °C

\u /

neutral alum ina

nH
.‘"X R

RX = MeO, P h S , n-BuNH

Equation 3.2 Epoxide ring opening with alumina catalyst

While looking for practical methods to apply for our substrate, we employed
alumina in reactions of l,10-phenanthroline-5,6 -epoxide with known and new
nucleophiles (Method A). From experiments we found that the results improved greatly
when using activated alumina; Basic Alumina Super I contained less water and worked
better than Brockmann I type reagent. In contrast to a previous literature report, 1 we also
found that alumina did catalyze reactions with sterically hindered and electron-deficient
ortho-substituted anilines (Entry 5, 7, 9, Table 1). However, the use of alumina has some
disadvantage including the use of excess nucleophile (3-4 equivalents,) and thorough
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quenching and washing with methanol for complete product recovery. Also, the reactions
are moisture-sensitive because water deactivates alumina. These reactions often required
purification by column chromatography to remove excess amines.

While searching for other methods, we found that magnesium perchlorate5
(Mg(C104)2) works as an efficient Lewis acid for ring opening of phenanthroline-5,6epoxide. The magnesium metal assisted aminolysis during the attack of the amine on the
metal-coordinated epoxide (Scheme 3.1).

M
HO

NHR

—N

N—

HNR

-N
N
p h en -e p o x id e

— N

2
am inoalcohol

Scheme 3.1 Epoxide ring opening with Lewis acids

In the presence of Mg(C1 0 4 )2 , reactions with 1.0-1.3 equivalents of nitrogen
nucleophiles in refluxing acetonitrile cleanly gave the corresponding amino alcohols in
very good yields and products could be isolated by a single recrystalization (Method B).
Additionally, reactions did not promote any side reactions, (e.g. dehydration) and were
suitable for sterically hindered and electrondeficient ortho-substituted anilines (Entries 6 ,
8

, 10, 12, Table 3.1). Furthermore, method B is also applicable to nucleophiles like

sodium azide, which could not be used with the alumina method due to poor solubility in
dichloromethane.
26
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Table 3.1 Chiral aminoalcohol derivatives (2a-j) via epoxide opening
Entry

Nucleophile

Conditionsa

Product (R =)

Yield % b

1

Aniline

Method A

2a (NH-C6H5)

85 (98)c

2
3

Method B
Benzylamine

4
5

2-Bromoaniline

2-Chloroaniline

2-Cyanoaniline

2c (NH-2-Br-C6H4)

Method A

Method A

2-Ethylaniline

Method A

2d (NH-2-Cl-C6H4)

14

Method A

2e (NH-2-CN-C6H4)

2f (NH-2-Et-C6H4)

155

51

149 (lit. 130131)°

86

146

97
2g (NH-4-Et-C6H4)

Method B

83

208

78

Sodium azide

Method B

2h (N3)

16

(R)-a-methylbenzylamine
4-methoxybenzylamine

Method B

2i (NH-(R)-(CH3)-CHc 6h 5)
2j (NH-CH2-4-(CH30)C6H4)

Method B

65

73

15

17

130 (lit. 128)c

86

Method B
4-ethylaniline

88 (76)0
83

Method B

12
13

Method A

85
87

Method B

10
11

2b (NH-CH2-C6H5)

Method B

8
9

86

Method B

6
7

Method A

Melting Points
°C
210 (lit. 206)°

87 (73)d

83 (lit. 99100)e

62

“Method A: Epoxide (0.255 mmol), nucleophile (3-4 eq.), A120 3 (86 eq.), CH2C12, 25° C, 24-48 h.
Method B: Epoxide (0.255 mmol), nucleophile (1.0-1.3 eq.), Mg(C104)2 (1.5 eq.), CH3CN, 80° C, 24-72 h.
bIsolated yields after column chromatography or recrystalization. Literature yields are reported in
parentheses. All products were characterized by 'H, 13C NMR, IR and MS spectroscopy.
“Reference 1.
^Prepared with sodium azide in acetone/water.
eAzido alcohol (2h) was isolated as hemihydrate.

Due to the symmetric structure of the epoxide, the overall reaction yielded
racemic product. In attempts to prepare the corresponding amino alcohols in optically
pure form, we used Jacobsen’s catalyst; a chiral (salen) chromium complex catalyst that
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mediates asymmetric ring opening o f epoxides with azidotrimethylsilane (TMSN3) as
nucleophile.

Jacobsen’s chiral salen ligand complexes with manganese (III) is a convenient
and effective tool for the stereoselective synthesis of the key side chain in the anti-tumor
drug Taxol.6 Replacement of manganese (III) by chromium (III), the (salen) Cr complex
served as an effective catalyst for the enantioselective ring-opening of mesc-epoxides
(Scheme 3.2) . 7 ' 9

x

;o

1. (ft, ft)-Jacobsen cat. (2 mol%), Et2 0 , rt
TSMNU
2. CSA, MeOH

OH

X = CH 2 ,(CH2 )2 , O, NCOCF3

N.
(ft, ft)-Jacobsen cat. =

N

t_gu

t-Bu

t-Bu

Scheme 3.2 Asymmetrically epoxide ring opening with Jacobsen catalyst

We tried to apply this catalyst by stirring 1.0 eq. of l,10-phenanthroline-5,6epoxide and 1.05 equiv. of TMSN3 with different solvents (CH2CI2, CH3CN), in the
presence of (5,^-Jacobsen’s catalyst (3 mol%) at various temperatures (r.t., 35, and 50
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°C), followed by the removal of the trimethylsilyl with trifluoroacid in methanol (Scheme
3.3).

O

N3

PTM S

TM SN 3
(S,S )-L (3 mol %)

N="
N
N
p h en -ep o x id e

pH

TFA
N
N
azido-silyl eth e r
in term ed iate

L=

N3

t-Bu

MeOH

N
N
azid o alcohol

t-Bu
t-Bu

t-Bu

Scheme 3.3 Proposed asymmetrically ring opening of 1,10-phenanthroline
epoxide with Jacobsen catalyst

Unfortunately, none of our attempted reactions were successful in producing the
corresponding azido alcohol. We speculate that the chromium in the Jacobsen catalyst
can chelate to the diimine site of the epoxide. Therefore, the phenanthroline derivative
can actually compete with the Jacobsen ligand (salen) and interfere with epoxide opening
reaction.

3.2 Resolution

We next tried to obtain amino alcohols in enantiomerically pure form via
resolution of racemates. Resolution remains a practical, effective and necessary technique
to prepare optically pure chiral compounds. Louis Pasteur pioneered this important
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approach, which involved the conversion of a mixture of enantiomers into a pair of
diastereoisomeric derivatives by reaction with optically pure reagents. Such optically
pure reagents are often available from natural sources such as tartaric, malic, and
mandelic acids, and alkaloids include brucine, strychnine, morphine and quinine.
R/S (enantiomers) + R* -» RR* + SR* (diastereomers)

The diastereomers RR* and SR* have physical properties (e.g. solubility, boiling
point, chromatographic behavior, etc.) which are often significantly different. Often,
enantiomers are separated because their diastereomeric salts differ in solubility and allow
for fractional crystallization.

Several resolution methods have been reported in the literature that use mandelic
acid10, dibenzoyl tartaric acid11' 13, and oxalic acid . 14 Recently chiral l , l ’-bi-2-naphthol
with inexpensive boric acid in acetonitrile and methanol have been employed for chiral
separation. 15 We focused on the formation and separation of diastereomeric salts between
racemic amino alcohols by using chiral acids such as S-mandelic, S-tartaric, D-camphoric
acid, which are commercially available.

Resolution of traTO-5,6-dihydro-6-N-(4-methoxybenzyl)-l,10-phenanthroline-5-ol
(4-MeO-benzyl-L) was achieved by reaction of racemic 4-MeO-benzyl-L with 1.2 equiv
of S-mandelic acid in methanol while heating. The mixture was then allowed to stand and
the less soluble diastereomeric salt, (+)-4-MeO-benzyl-(S)-2-hydroxy-2-phenylacetate,
precipitated or crystallized out (Scheme 3.4) was separated from the (-)-4-MeO-benzyl-
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(*S)-2 -hydroxy-2 -phenylacetate was isolated after filtering and washing with coldmethanol.

OMe

OMe

HO

HO

H2N

HN

OMe

HO

HN

N
N(+)-4-MeO-benzyl-(S)-2hydroxy-2 phenylacetate

precipitate
INNaOH, CH3CI

(+)-4-MeO-benzyl-L

(S)-mandelic acid
OMe

OMe

MeOH

filtrate
4-MeO-benzyl-L

(rac)

HQ

INNaOH, CH,CI

HoN

HQ

HN

=N
N=
(-)-4-MeO-benzyl-L

(-)-4-MeO-benzyl-(S)-2hydroxy-2 phenylacetate

Scheme 3.4 Resolution of 4-MeO-benzyl adduct with S-mandelic acid

'fl NMR determined the efficiency for separation of diastereomeric salts (Figure 3.1).
The (+)- and (-)-4-MeO-benzyl-(S)-2-hydroxy-2-phenylacetate salts yielded singly pure
amino alcohol products following base extraction. The

[ oc] d

in methanol at 20°C for (+)-

and (-)-4-MeO-benzyl adducts are +12.1° and -13.4°, respectively.

31

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 3.1 *H NMR spectra of 4-MeO-benzyl-(S)-2-hydroxy-2-phenylacetate
diastereomeric salts; absolute stereochemistry has not been established

A similar method was applied to separate diastereomeric tram-5, 6 -dihydro-6 -./Va(+)-methylbenzyl-l,10-phenanthroline-5-ol

isomers

(a(+)-methylbenzyl-L) which

could not be separated by simple column chromatography or recrystallization. The white
crystal (S,S)- a(+)-methylbenzyl-(5)-

2

-hydroxy-2 -phenylacetate complex salt was

separated from (R,R)- a(+)-methylbenzyl-(5)- 2-hydroxy-2-phenylacetate complex salt
by filtering and methanol washing. Neutralization of the salts with base afforded
enantiopure amino alcohols (Scheme 3.5). Proton NMR spectra showed the (S,S)- and
(R ,R )- a(+)-L were obtained with >99% purity. The

[ oc] d

at 20°C for (S,S)- and (R,R)-

a(+)-adducts are +29.8° and -5.3°, respectively.
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OH

Ph

W

N=
(S,S)- <x(+)-methylbenzyl-(S)2 -hydroxy-2 -phenylacetate

HQ

HN

precipitate
1N NaPH, CH3 CI

(S)-mandelic acid

=N

N-

(S,S)-a-(+)-L

PH

MeOH

HQ

CP;

filtrate

HN

.'! b n

1N NaPH, CH3CI
Ph

=N
N=
a(+)-methylbenzyl-L

=N

N=

(R,R)-a-(+)-L
■=N

N=

(R,R)- a(+)-methylbenzyl-(S)2 -hydroxy-2 -phenylacetate

Scheme 3.5 Resolution of a(+)-methylbenzyl-L with S-mandelic acid

3.3 5,6-Oxazolidinone-l,10-Phenanthroline Derivatives

In order to avoid side reactions of the hydroxyl group (-OH) and the formation of
competing diastereomeric conformers, we linked the functional groups in the 5- and 6 positions (Figure 3.2) in the form of its oxazolidinone. Its conformer is locked in the
pseudodiequatorial position.
H

RHN

H

HO

diequatorial (syn) conform er

diaxial (anti) conform er

Figure 3.2 Side view of diastereomeric conformers
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Oxazolidinones are a well-known class of compounds in medicinal chemistry. In
1978, 3-(p-alkylsulfonylphenyl)oxazolidinone derivatives were first shown to be active
against plant diseases, 16 and their antibacterial properties were discovered six years later.
Besides that, oxazolidinone chiral auxiliaries are often used for diastereoselective
Michael additions, 17 alkylations, 18 aldol condensation, Diels-Alder, and other reactions.

Oxazolidinones can be formed via reactions between aminoalcohols and a number
of reagents. The use of phosgene or diethyl carbonate provided the most direct route to
oxazolidinones as outlined in Scheme 3.6 . 19-21
(triphosgene)

(1R ,2R )-2-am ino-1,2diphenylethanol

(4R,5R)-4,5-diphenyloxazoIidin-2-one

Scheme 3.6 Preparation of 4,5-diphenyloxazolidin-2-one with phosgene

Ethyl chloroformate can also be employed; it first reacted with the amine of
amino alcohols and the resultant carbamate can then be cyclized in the presence of base
to afford the corresponding oxazolidinone (Scheme 3.7) . 2 2
(ethyl chloroformate)

BnHN
4-(hydroxymethyl)-4methyloxazolidin-2 -one

Scheme 3.7 Preparation of 4-(hydroxymethyl)-4-methyloxazolidin-2-one
with ethyl chlorofomate
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We employed the same method to convert tram-5,6 -ami noalcohol adducts into
their oxazolidinone derivatives. The 5,6-dihydro-aminoalcohol-l,10-phenanthrolines
reacted with ethyl chloroformate in the presence of different bases (Et3 N, NaH), and
solvents (THF, MeCN), at 0 °C to room temperature under argon atmosphere. The
desired products were obtained with low to moderate yield (17-45%) after purification.
More side products were produced when we used NaH as base in THF or MeCN as
solvent.

To improve the yield for this reaction, other reagents (triphosgene, N,Ncarbonyldi-imidazole) and bases (Li'-OBu, NaOCH3) were tested. We found that
oxazolidinone derivatives can be prepared in good yield with the use of triphosgene ( 1 . 0
equiv), a safer phosgene replacement, and Li'OBu (3.0 eq.) in anhydrous CH2 CI2 at 0 °C
to room temperature under argon atmosphere (Scheme 3.8). After purification via silica
gel chromatography, the desired products were isolated in good yields (73-91%).

HO

O
0

NHR
O

NR

LfOBu / CH 2CI2

i-O

(74%)

* R,R(79%); S,S,R(91% )

Scheme 3.8 Preparation of 5,6-oxazolidinone-l,10-phenanthroline
derivatives with triphosgene

35

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

However, the carbonylation was unsuccessful with o-substituted aniline
derivatives. This may be due to the hindering effect of the substituent in the ortho
position, which prevents amine unit to react with triphosgene.

3.4 NMR Studies

The 5-hydroxy (OH) and

6

-amine (NHR) substituents on the phenanthroline

ligands can interconvert between pseudoaxial and equatorial position. This alters the
ligand twist for equilibrating diastereomeric conformers that affects the ligand chelation
site (NCCN, Figure 3.2).

Metal-ligand complexes play an important role in asymmetric catalysis by
creating chiral steric barriers and controlling torsional twists. To optimize our ligands we
studied vicinal coupling constants to determine the syn and anti ratio of conformers.

In hydrocarbons, the spin of the hydrogen nucleus in one C-H bond is coupled to
the spin of those hydrogens in adjacent C atoms. This H-C-C-H interaction (Figure 3.3A) is expressed through its vicinal coupling constant, 3J. The spin-spin splitting patterns
follow the n + 1 rule (Figure 3.3-B). 3J measures the magnitude of the splitting, and the
actual magnitude of 3J between two adjacent C-H bonds is depended on the dihedral
angle a connecting these two bonds (Figure 3.3-C) . 23
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Figure 3.3 Spin-spin splitting and dihedral angle of vicinal protons

Due to the asymmetric structure of tram-5, 6 -di-substituted-l ,10-phenanthrolines,
H(5) and H(6 ) are non-equivalent and couple to each other. Their spin-spin splitting
appears as two doublets in the proton spectrum. 'H NMR coupling constants were studied
for various ligands and results compared to calculated values for tra«v-4-MeO-benzyl-L
(A,

Figure

3.4)

and

3-(4-methoxybenzyl)-3,3a-dihydro-oxazolo[5,4-

f][l,10]phenanthrolin-2(l lbH)-one (oxa-4-MeO, (B) Figure 3.4) as summarized in Table
2.

O CH ,

HO

h

54

HN

- ^ - h

//

O

6

N

X
=N

N

N=

N

oxa-4-MeO

4-MeO-benzyl-L
(A)

Figure 3.4 Vicinal protons (H5 and He) in 4-MeO-benzyl-L and oxa-4-MeO
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Table 3.2 Comparison of calculated and experimental data

4-MeO-benzyl-L

9.5,[aJ 5.9[bJ

*H NMR,
[Hz]
for anti conformer
(calculated)
1.7

4-MeO-benzyl-L'H+

4.4,[b] 3.7[c]

1.7

oxa-4-MeO

13.9[a]

H NMR, Is#
[Hz] (observed)

H N M R ,/ 5 ,6 [Hz]
for syn conformer
(calculated)
13.0

1

12.7
14.2

[a] Recorded in CDC13, [b] Recorded in MeOD, [c] Recorded in D20

The computational studies for J$y of ligands (A) and (B) were done by Professor
John Miller at WMU which helped to determine preferred conformations in conjunction
with ‘id NMR experiments.

For trans-4-MeO-benzyl-L (A), the Js,6 for H(5) and H(6 )

were 9.5 Hz (syn preferred) and 5.9 Hz (anti preferred) in CDCI3 and MeOD,
respectively. Changing from an aprotic solvent to a protic one caused a reverse in the
anti/syn ratio from 31/69 to 63/37, (Boltzman distribution ratio). The protic solvent
perhaps breaks up the intramolecular H-bonding between the amino and alcohol group in
the pseudodiequatorial conformer forming very bulky sovation shells that prefer a
pseudodiaxial arrangement to avoid allylic strain. A similar switching helicity was made
when (A) was protonated with HC1 gas, shifting the equilibrium further toward the anti
isomer A H (4.4 Hz, 75% in MeOD and 3.7 Hz, 82 % in D 2 0).

Cyclization of (A) through carbonylation with triphosgene yielded oxazolidinone
(B), which permanently locked the 5- and 6 -sustituents in the syn conformation. The
experimental value of /s ,6 (13.9 Hz) was very close to the calculated value (14.2 Hz).
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Figure 3.5 shows the change in chemical shift and coupling constants for methine and
benzyl protons.

Figure 3.5 'H NMR spectra of A (above) and B (below) in CDCI3

Oxazolidinone derivatives ((S,S) and (i?,i?)-oxa-oc(+), oxa-benzyl, and oxa-4-Etanilyl) showed identical /s ,6 values (13.9 Hz) in *H NMR experiments.

Ligands (A) and (B) were also studied with solid-state data from X-ray
diffraction, carried out by Professor Marc Perkovic at WMU. Amino alcohol (A)
preferred a syn arrangement with a dihedral angle (NCCN) of 21°, which was close to the
calculated value 19.6°, and 23° for oxazolidinone (B) where the calculated value was
21.8° (Figure 3.6).
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Figure 3.6 Molecular structure (ORTEP view) of 4-MeO-benzyl-L (above)
and oxa-4-MeO (below)

3.5 C2-Symmetric Ligand

Among the vast number of chiral ligands that have been prepared so far,
nevertheless a relatively small number of them stand out because of their broad
applicability. Ligands are capable of exerting a high level of enantiocontrol in many
different metal-catlyzed reactions. Often C2 symmetry can beneficially affect
enantioselectivities.
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Similarly to epoxides, aziridines are valuable synthetic intermediates because the
strained three-membered ring can be opened by a variety of nucleophiles. Aziridines can
be found in natural products such as mitomycin, porfiromycin, and mitiromycin, which
are potent antitumor and antibiotic agents (Figure 3.7).24,25

CH 20 C (0 )N H 2

( PY
O
Mitomycin A:
Mitomycin B:
Mitomycin C:
Porfiromycin:

X = OMe, Y = Me, Z = H
X = OMe, Y = H, Z = Me
X = NH2, Y = Me, Z = H
X = NH2, Y = Me, Z = Me

Figure 3.7 Mitomycins, aziridine containing, antitumor and antibiotic agents

Because aziridine structures are closely related to epoxides; the approaches to
their syntheses are very similar. The simplest preparation of aziridines is the ring closure
of a (3-functional ethylamine and the required precursors for this route to aziridines is
usually a 1,2-amino alcohols.
To apply the concept of C2 symmetry to our phenanthroline ligand template, we
introduced identical substituents in the 5- and 6-positions. Similar to the preparation of
/ram'-5,6-dihydro-aminoalcohol-1,10-phenanthroline, the C2-fr<ms-5,6-dihydro-diamine1,10-phenanthroline was synthesized by aminolysis of 5,6-dihydro-aziridine-l,10phenanthroline intermediate using a Lewis acid catalyst (Scheme 3.9).
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I

Lew is acid
aziridine

C2-diam ine

Scheme 3.9 Acid salt’s metal catalyzes aziridine ring opening

Aziridines can also be utilized as ligands in asymmetric catalysis as outlined in
Scheme 3.10.26

Ph

P h.

Ph 0~ s ~
0 4, Ligand^ Ph
T o lu en e, -78°C
(E )-1,2-diphenylethene

90%
95% e e

(1 S ,2 S )-1,2-diphenyl
eth an e-1 ,2 -d io l

Scheme 3.10 Asymmetric dihydroxylation using an aziridine containing ligand

The preparation of la,9b-dihydro-l-((R)-l-phenylethyl)-lH-azirino[2,3-f][l,10]
phenanthroline (a(+)-aziridine, Scheme 3.11) was accomplished by mesylation of a
diastereoisomeric mixture of (5R,6R) and (5S,6S) of 6-((R)-l-phenylethylamino)-5,6dihydro-l,10-phenanthrolin-5-ol according to the literature procedure.27 The aziridine
product was generated via spontaneous intramolecular mesylate displacement in 80%
yield.
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PH3
N

Ph

N

MsCI, Et3N/CH2CI2
24h, 0°C - r.t., 12h
80%

N

N

a(+)-methylbenzyl-L

N

a(+)-aziridine

Scheme 3.11 The preparation of a(+)-aziridine derivative

Ring opening of a(+)-aziridine was carried out with (R)-a-phenylethylamine in
the presence of lithium or magnesium perchlorate, the diastereomeric ((VR,5R,6R,VR)
and

( l ’i?,55',6iS,, r/?))

of

tram-5,6-dihydro-N5,N6-bis((R)-l-phenylethyl)-l, 10-

phenanthro-line-5,6-diamine (C2 (RRRR), C2 (RSSR)) product were separated by column
chromatography using SiC>2 , CHCh/3% MeOH (Scheme 3.12) and thus isolated in
enantiopure form in 79 % yield.

H3 C/, ^Ph
y^ m

r.H„

Me

Me

Me

Me

^ P h , M eCN
//

\

\=

k,

//
^ , =

\
/

M g(C I04)2 or LiCI04
80 °C , 79%
C 2(RSSR)

a(+)-aziridine

C 2(RRRR)

Scheme 3.12 Preparation of C2 (RRRR) and C2 (RSSR) diamine derivatives
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Chapter 4: Metal Complexes of 5,6-Disubstituted

1 ,1 0 - P h e n a n t h r o lin e s

Many ions and organic functional groups can form complexes with metals. The
concept of a metal complex originated in the work of Alfred Werner, who, in 1913, was
awarded the first Nobel Prize in inorganic chemistry. The formation or presence of bonds
between two or more separate binding sites within the same ligand and a single atom is
described as chelation. The word chelate was first applied in 1920 by Morgan and Dew,1
who stated: “The adjective chelate, derived from the great claw or chela (chely- Greek)
of the lobster or other crustaceans, is suggested for the caliper like groups which function
as two associating units and fasten to the central atom so as to produce heterocyclic
rings." Metal complexation is of widespread interest. Many scientific disciplines study it,
especially organic chemistry where transition metal-catalyzed reactions are becoming
increasingly important tools. Various metals, combined with suitable organic ligands,
form catalysts that can be efficiently used for the formation of C-C, C-N and C-O bonds
in functionalized organic molecules.

In asymmetric synthesis, the metal complexes (chiral catalysts) often consist of
transition metals and chiral ligands. Most chiral ligands are small heterocyclic
compounds that rely on sterically demanding functional groups to control the
conformation of their ring system. Under ideal circumstances, the conformation of a
chiral catalyst should be constrained to ensure that its prochiral center reacts with a
reagent via diastereoisomeric transition states, and are sufficiently different in energy to
ensure that only a single diastereoisomer is formed as product. The complex interplay
within the catalyst is often subtle, and many examples exist where small changes in bond
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angles, or heteroatom hybridization can result in large changes in diastereoselectivities.
For example, asymmetric induction during a-substitution in Scheme 4.12 was depended
upon the nitrogen protecting group.

O

0^\

R

i) LHMDS, THF, -78°C
ii) Mel
R S u b stitu e n t

d. e.

tBu
Ph
O Ph

50%

,0
'M e
R

88%
96%

Scheme 4.1 Nitrogen protecting group affects diastereoselectivity

1,10-Phenanthroline can form many different metal complexes. This property has
been exploited for the detection of metal ions since 1930’s and similar coordination
chemistry can be achieved in 5,6-dihydrophenanthroline derivatives. The change of
hybridization in the 5- and 6- positions from sp2 to sp3 causes a change of the N-C-C-N
dihedral angle and it affects the diimine chelating site. To investigate how this
modification of ligands will affect the catalytic function before and after metal
coordination, we prepared 1,10-phenanthroline complexes with several transition metals
such as Pd, Ni, Zn, and Ru. Additionally, we studied chiral ligand structures through
solid state analyses to better understand the effect of ligand modification.
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4.1 Palladium-1,10-PhenanthroIine Complexes

4.1.1 Dichloropalladium-l,10-Phenanthroline Complexes
Palladium (Pd) is a rare silver-white transition metal of the platinum group. It is
primarily used as an industrial catalyst, i.e. to speed up hydrogenation or
dehydrogenation reactions as well as petroleum cracking. Pd-based catalysts play an
indispensable role in synthetic organic chemistry. Particularly for asymmetric C-C bonds
formation, the catalyzed-asymmetric allylic reaction is now a widely used process in
organic chemistry (Scheme 4.2).3'5

0A c

n

n

BSA, THF, 60°C
(£)-1,3diphenylallyl
a c e ta te

O

(d b a)3P d 2 . CHCI3
& B IN A P

p en tan e -2 ,4 -d io n e

O

P h ^ s ^ 'P h
73% yield, 92% e e

(+)-BINAP =

Scheme 4.2 Pd-catalyzed allylic alkylation4

A dichloropalladium (II) complex with a bidentate donor ligand is found in the basic
metal complex structure, a square planar metal arrangement. Its structure contains a Pd
metal atom coordinated with two chlorine atoms and a ligand that has two binding sites to
Pd. We reacted our ligands with dichloropalladium (II) to study the corresponding
complexes.
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The dichloropalladium-1,10-phenanthroline complexes (A-C) were prepared by
modified literature procedures (Scheme 4.3).6,7 5,6-Oxazolidinone-1,10-phenanthroline
derivatives were mixed with bis(acetonitrile) palladium chloride, Pd(CH 3 CN)2 Cl2 , or
palladium(II) chloride, PdCf, in CH2 CI2 heated at 30°C for 12hrs, affording very good to
nearly quantitative yields of the corresponding metal-complexes.

-R

Pd(CH3CN)2Cl2
or PdCI2

—N

N—

N=
Pd

R — H2C—

h —OMe
98%

r

= h£

o

r

. ^ q

Et

95%

96%

Scheme 4.3 Palladium-1,10-phenanthroline complexes

From ’ff NMR spectra in DMSO-d6, the

of (A, C) free ligands were compared

to those of metal complexes. Coupling constants changed from 13.91 Hz to 14.65 Hz in
both cases. Using the Karplus correlation, the increase of the /s,6 value suggests that the
dihedral angle NCCN has changed to a larger angle after complexation.8 The final proof
for this will only be available through solid-state analysis.

Unfortunately, attempted re-crystallizations of ligands A and C with various
solvent systems (DMSO, DMSO/water, DMF), at different temperatures and techniques
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(solvent evaporation, solvent liquid/vapor diffusion, cooling, gradual cooling under
vacuum) were unsuccessful. The complexes (A & C) were characterized by 'H, 13C
NMR, and melting point. The study of complex B, due to its insolubility in most organic
solvents, even in hot DMSO was limited.

The C2 -symmetrical ligands, C2 (RRRR) and C2 (RSSR), were also complexed
to dichloropalladium, following similar procedures (Scheme 4.4).

Pd(CH3CN)2CI2
or PdCI2
Pd
c

C2 (RRRR)

f

SC I

C2 (RRRR)-PdCI2

(D)

Pd(CH3CN)2CI2
or PdCI2

Pd

cf

C2 (RSSR)

sci

C2 (RSSR)-PdCI2

(E)

Scheme 4.4 Palladium-diamine- 1,10-phenanthroline complexes

'H NMR confirmed palladium coordination with C2 ligands at the diimine site
instead of the diamine moiety. In the C2 (RRRR)-PdCl2 (D) complex, we observed
heteroaromatic proton resonance shifts downfield as follows: 5 8.59 —» 8.82 ppm for H’s
at 2- and 9- position, (7.35-7.40) -> 7.61ppm and 7.80 ppm for H ’s at the 3,8-, and the
4,7- position, respectively (Figure 4.1). Moreover, the strong complexation capability of
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the diimine functionality was evident in the solid state. The crystal structure of C 2
(RRRR) showed that a CHCI3 molecule was chelated at the diimine site (Figure 4.2).

Similar effects were seen for the proton resonance of the C2 (RSSR)-PdCl2 complex.

Figure 4.1 Comparison of C2 diamine ligand with its palladium complex

Figure 4.2 Crystal structure of C2 (RRRR) chelated to CHCI3
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4.1.2 (7T-Allyl)Palladium 1,10-PhenanthroIine Complexes
Metal

71

-complexes are organometallic compounds, containing a bond between

carbon and a delocalized 7t-electron system and may therefore be considered to be
bonded to two or more contiguous ligands atoms. 7T-Allyl complexes are of significant
utility in organic chemistry. Amongst the most noteworthy and commonly used are
allylpalladium(II) complexes which react with nucleophiles, allylstannanes and
allylboranes.

We employed (7i-allyl)palladium chloride dimer to synthesize (7t-allyl)palladium1,10-phenanthroline complexes. 5,6-Dihydro-6-(4-methoxybenzylamino)-1,10-phenanthrolin-5-ol (l,3-ri3-propenyl)palladium trifluoro-methanesulfonate (4-MeO-benzyl-PdOTf, F) was prepared using a known procedure.9' 11 The method initially involved a
reaction of the allylpalladium chloride dimer with the silver salt, AgCF3 S0 3 , through
ligand and metal exchange. Formation o f the complex occurs upon addition of the 5,6dihydro-6-(4-methoxybenzylamino)-l,10-phenanthrolin-5-ol ligand (Scheme 4.5).
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Scheme 4.5 (ix-Allyl) palladium complexes with 1,10-phenanthroline derivatives

To understand the change of the NCCN dihedral angle after complexation, it was
important to obtain structural information for these (7T-allyl)palladium complexes. The
structure of complex F was determined by X-ray analysis and NMR spectroscopy and
compared to computational calculations.

The crystallization of metal complexes was achieved at -10°C by a solvent
diffusion technique under approximately stoichiometric conditions. An ORTEP
representation of the ligand complex is shown in Figure 4.3. The geometry of the
complex shows that the Pd is coordinated to two nitrogen atoms at the chelated site of the
ligand yielding a N-C-C-N dihedral angle of -8.6°; the free ligand has an angle of 21°.
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Figure 4.3 Molecular structure (ORTEP view) of the complex F

Computational chemistry DFT studies using B3LYP method, mixed basis sets
(LANL2DZ, in the pseudopotential mode for Pd, and 6-31G* for O, H, C, N) have been
performed to visualize the geometry and electronic structure of complex F in the ground
state. The optimized structure revealed a NCCN dihedral angle of 12.6° (Figure 4.4).

Figure 4.4 Gaussian view window showing the N-C-C-N dihedral angle value
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Complex F formation can be followed by *H NMR in DMSO-d6. The chemical
shift of the terminal rc-allyl protons changes significantly for several protons (5
5.85—>6.05 ppm for H-2; 4.24—>4.51 ppm for Hsyn; 3.39—>3.55 ppm for Hanti), and

heterocyclic protons

(8

8.64—>8.89 ppm for H ’s at the 2- and 9- position; 7.86—>8.27,

7.82—>8.21 for H ’s at the 4- and 7- position; and 7.40—>7.79 for H ’s at 3- and 8position). The Js,6value was not change (4.76 Hz).

The

5,6-oxazolidinone-6-(4-methoxybenzylamino)-1,10-phenanthroline( 1,3-r)3-

propenyl)palladium trifluoromethanesulfonate (oxa-4-MeO-Pd-OTf, G) and (5R,6R)5,6-dihydro-N5,N6-bis((R)-1-phenylethyl)-1,10-phenanthroline-5,6-diamine rf-propenyl)
palladium trifluoromethanesulfonate (C 2 (RRRR)-Pd-OTf, H) complexes were prepared
in the same way as complex F.

The formation of complex G was confirmed by comparing !H and 13C NMR
spectra in CDCI3 , both before and after complexation with the Pd dimer. The splitting and
chemical shifts of the heterocyclic protons changed from “triplet” to “doublet-doublet” (5
8.82—>8.78 ppm.), (8 7.86-H5.21 ppm) for protons at the 2-, 9-, and 4-, 7- position,
respectively and “doublet-doublet” to “doublet-doublet-doublet” (8 7.38—>7.76 ppm).
There were two additional resonance peaks of sp2 carbon and one more of sp3 for the izallyl carbons in the decoupled carbon NMR spectrum. Furthermore, comparison between
complex G and the Tr-allyl-Pd dichloride dimer in CDCI3 also confirmed complexation.
The 7r-allyl resonance in complex G shifted downfield (8 5.46—>5.92 ppm for H-2;
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4.11—>-4.40 ppm for Hsyn; 3.04—>3.55 ppm for Hanti). The Js,6 value in G also increased
from 13.91 to 14.65 Hz (Figure 4.5).

1

— N

87

— ■

77

8.2

72

6.7

5.

47

5.2

4,2

GOH5

IJ
8.2

8.2

52

42

3.2

Figure 4.5 H NM R spectra o f 4-oxa-MeO (above) and
its (7r-allyl) palladium complex (below)

The crystallization o f the C2 (RRRR)-Pd-OTf (H) complex was performed in the
same way as for F and yielded tiny yellow-needline crystals. Unfortunately, the complex
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structure cannot be examined by X-Ray analysis due to its labile physical property;
however, the formation of its (7t-allyl)palladium complex was verified by *H NMR.

4.2 Ruthenium - 1,10-Phenanthroline Complexes

Ruthenium is an element with the widest range of oxidation states in the periodic
table (from -2 to +8). The metal-complexes of each oxidation state can assume several
coordination geometries. The wide range of oxidation states, coordination geometries,
and tunable properties result in the ability of ruthenium complexes to catalyze a
significant range of chemical transformation such as ring-closing metathesis,12
hydrogenation,13 cyclopropanation,14 and many more. In addition, ruthenium complexes
have been used as chiral building blocks for supramolecular chemistry,15 or as chiral
probes for biological molecules (DNA, polynucleotides).16 The majority of the ruthenium
complexes used are in the +2 oxidation state. Octahedral hexacoordinated ruthenium(II)
complexes bearing 2,2’-bipyridine ligands (bpy) have been used extensively as visible
light-active photosensitizers because they exhibit metal-to-ligand charge transfer (MLCT)
excited states.17' 19

In order to broaden the scope of metal-1,10-phenanthroline complexes we focused
on complexation with Ru(II). The cA-(bpy)2 RuCl2 2 H2 O was prepared in 68-70% yield
following a literature procedure,20 and used as ruthenium metal source. The cis(bpy)2RuCl2.2H20 was confirmed by measuring UV absorption (547 and 368 nm) and
comparison with literature values (550 and 375 nm).21 The

[Ru(bpy)2 (phen)](PFe) 2

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

complexes were obtained after refluxing cw-(bpy)2 RuCl2 .2 H2 0 and the ligands in
aqueous methanol, followed by addition of NH 4 PF6 (Scheme 4.6).
OMe —

1.reflux, 16 h
c/s-(bpy)2RuCI2 . 2H20

+
2. NH4PF6

J

K

Scheme 4.6 [Ru(bpy)2 (L*)](PF6 ) 2 complexes

Attempted recrystalization of complexes I, J, and K in different solvent mixtures
(DCM/Hexanes, acetone/ether, DMSO/water), and subsequent ion exchange with CIO4 ,
OTf were unsuccessful. Materials were characterized by *H, 13C NMR and melting point.

4.3 Zinc and Nickel-1,10-Phenanthroline Complexes

Zinc and Nickel complexes of 1,10-phenanthroline ligands were prepared using
the same literature procedure. 2 2 The authors reported a method for dichloro(l,10phenanthroline-2,9-dicarbaldehyde dioxime)zinc as well as (dichloro)(DMSO)-(l,10phenanthroline-2,9-dicarbaldehyde dioxime)nickel for the purpose of X-ray diffraction
study.
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4.3.1 Zinc-1,10-Phenanthroline Complex
In our lab we used 5,6-oxazolidinone-6-(4-methoxybenzylamino)-l,10-phenanthroline as ligand to prepare dichloro(5,6-oxazolidinone-6-(4-methoxybenzylamino)l,10-phenanthroline)zinc and nickel complexes; ZnCl2 , and NiBr were used as metal
sources. The ligand reacted with metal salt under (1:1) metal/ligand ratio in DMSO, and
was followed by vapor diffusion o f DCM (Scheme 4.7), no solid formed. Additional
unsuccessful crystallization attempts were carried out at room temperature.
OMe

Z nC I2, M eO H

Cl'

L

'Cl

Scheme 4.7 Dichloro- 1,10-phenanthroline-zinc complex

After the ligand reacted with ZnCl2 in MeOH overnight at room temperature the
formation o f dichloro [5,6-oxazolidinone-6-(4-methoxy-benzyl-amino)-1,10-phenanthroline]zinc (L) was corroborated by *H NM R analysis. The proton resonance peaks in the
2- and 9- position (8 8.83 ppm) changed from “triplet” to “doublet" after complexation;
same as for H ’s in the 4-, 7- and 3-, 8- position, the resonance peaks changed from
“triplet” to “doublet-doublet” and from “doublet-doublet” to “doublet-doublet-doublef
and shifted down field (5 7.86 -» 8.21 ppm), (8 7.39 -» 7.82 ppm), respectively. The
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methine protons in the 5-, 6- position were also shifted downfield (Figure 4.6). The Js,6
value changed from 13.91 to 14.28 Hz after complexation.

OMe

(mCDCb)

8 .9

8.4

?.9

74

S3

S4

5.9

5.4

4.9

4.4

Figure 4.6 'H NMR spectra of 4-oxa-MeO (above) and
4-oxa-MeO-ZnCl2 (below)

4.3.2 Nickel-1,10-Phenanthroline Complex
The

dibroro[5,6-oxazolidinone-6-(4-methoxy-benzyl-amino)-1,10-phenanthro-

line]nickel complex was prepared using NiBr2 instead of ZnCh. No crystals or precipitate
formed after different recrystalization methods were explored. Unfortunately, nickel
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complexes could not be characterized by NMR spectroscopy due to their paramagnetic
properties.
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CHAPTER 5: PALLADIUM CATALYZED ASYMMETRIC ALLYLIC
ALKYLATION
The palladium-catalyzed substitution reaction of allylic substrates has been
examined thoroughly during the last four decades, beginning with Tsuij’s pioneering
work in 1965.1 The first allylic substitution reaction in the presence of palladium catalyst
was reported in 1970,2,3 and in 1973 Trost published the first asymmetric version.4
Palladium-catalyzed asymmetric allylic alkylation reactions are widely used in organic
chemistry, particularly for asymmetric carbon-carbon bond forming reactions.5'8 It also
has become the standard test reaction to determine the effectiveness of new ligands.
Specifically, (£)-l,3-diphenylpro-2-enyl acetate has been used as the substrate and many
ligands have been applied to this enantioselective alkylation of this compound (Scheme
5.1).8

OAc
'P h

[Pd(Ti3-C 3H5)Cl 2]/ L*

C H (C 0 2C H 3)2

BSA. KOAc, CH 2( C 0 2CH 3)2

(E)-1,3-diphenylpro2-enyl a c e ta te

P I T '^

Ph

dim ethyl 2-((E)-1,3-diphenylallyl)
m a lo n ate

Scheme 5.1 Allylation of {E)-\ ,3-diphenyl-2-propenyl acetate

5.1 Mechanism and Catalytic Cycle with Palladium

To obtain good stereoselectivity the incoming nucleophile needs to discriminate
enantiotopic faces of the rt-allyl complex of (£)-l,3-diphenylpro-2-enyl acetate (Figure 5.
I).7 Nucleophilic attack usually occurs from the face opposite the metal and an overall
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retention of stereochemistry is achieved. The induction at the 7t-allyl depends upon the
nature of the allyl moiety with respect to the chiral space about the ligands.

Figure 5.1 Nucleophile attacking on 7t-allyl complex

According to the widely accepted mechanism of Pd-catalysis asymmetric allylic
substitution proposed in “Catalytic Asymmetric Synthesis” by Trost and Lee,9 the
catalytic cycle begins with the formation of an r\2 -Pd° complex and subsequent
dissociation of the leaving group which provides the r\3 -Pd+2 complex. A nucleophile
moves toward displacing the Pd with inversion at either the proximal or distal terminus of
the allyl moiety to generate the ri2 -Pd° complex. Decomplexation of Pd regenerates the
catalyst and the product is released (Scheme 5.2).

Scheme 5.2 Catalytic cycle with palladium
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In order to investigate the performance of our new ligands in asymmetric catalysis
and particularly in asymmetric alkylation of (£)-l,3-diphenylpro-2-enyl acetate, we
tested the reaction shown in Scheme 5.1. (£)-l,3-Diphenylpro-2-enyl acetate was
prepared according to the literature procedure,10 by reacting l,3-diphenyl-3-hydroxyprop1-ene with acetic anhyride in the presence of DMAP as catalyst. After purification (E)l,3-diphenylpro-2-enyl acetate was isolated in good yield (80%, Scheme 5.3), which was
confirmed by NMR (’H, I3C).

OH
P h ^^ ^ ^ P h
1 ,3-diphenyl-3hydroxyprop-1 -en e

A c 20

OA c

DM AP/pyridine
0°C -»r.t.

Ph^^^^^^^Ph
(E)-1,3-diphenylpro2-enyl a c e ta te

Scheme 5.3 Preparation of (E)-1,3-Diphenyl-2-propenyl acetate

The Pd-catalyzed alkylation of the allylic acetate was carried out in the presence
of a (7t-allyl)-palladium-ligand complex, generated in situ from 2.5 mol% [Pd(r|3C3H5)C1]2 and 10 mol% of our ligand. Dry dichloromethane was chosen as solvent based
on the literature discussion,10 stating that solvent polarity does affect the reaction. For
example,

DMSO

gives

shorter

reaction

time

but

lower

enantioselectivities.

Dichloromethane alone was impracticable due to the low solubility of the sodium salt of
dimethyl malonate. However, the use of N, O - bis (trimethylsilyl) - acetamide (BSA)
and sodium acetate (NaOAc) as bases to deprotonate dimethyl malonate avoided these
difficulties and provided the product. The transformation was complete after 24 h and our
preliminary results are summarized in Table 5.1.
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Table 5.1 Allylic alkylation’s result data
Entry

Nucleophile

Ligand

Isolated Yield (%)

E. e. (%)

1

NaCH(C02CH3)2

(rac)-oxa-4-MeO

81

oa-b

2

NaCH(C02CH3)2

(+)-oxa-4-MeO

80

0a’b

3

NaCH(C02CH3)2

(5',5)-oxa-a(+)

86

l a, 0b

4

NaCH(C02CH3)2

C2 (RRRR)

86

14a, 0b

5

NaCH(C02CH3)2

C2 (RSSR)

81

3a, 0b

~|1 enantiomeric excess be determined by *H NMR with (+)-Eu(hpc) 3
aa tThe
b The enantiomeric excess be determined by Daicel OD-H 25x0.46 cm (L x I.D.) at X =
254 nm; flow rate 0.5 mL/min; eluent: Hexanes/IPA (200:1), 0? = 23.5 ts=25.0 min.
J

. . _______ •

J

1 ...

The product was analyzed with chiral shift reagent, (+)-Eu(hpc) 3

and chiral

HPLC methods to determine the enantiomeric excess of product.

5.2 NMR With Shift Reagents

Enantiomers cannot be differentiated in the NMR spectrum because the probe is
isotropic. However, diastereomers display different chemical shifts. Diastereoisomeric
complexes are formed by mixing the chiral shift reagent (+)-Eu(hpc) 3 with racemic
dimethyl 2-((E)-1,3-diphenylallyl)malonate product. (+)-Eu(hpc) 3 is a Lewis acid and
Eu3+coordinates with one or two oxygen atoms in carbonyl groups (Figure 5.2).
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Figure 5.2 Interaction of (+)-Eu(hpc) 3 with malonate product

The proton resonance from the malonate methyl groups of diastereoisomers
complexes showed 2 singlets and a doublet at 4 ppm. region, in which the singlets were
from different enantiomers (Figure 5.3). The singlet with the highest chemical shift ppm
corresponds to the (7?)-enantiomer.10
(S )-e n a n tio m e r

1.

4.2

4 0

3

•3.3

3 .7

X ; p a rts p e r Million : 1H

Figure 5.3 Chemical shift of methyl protons in malonate enantiomers

5.3 Chiral HPLC

A chiral column (Daicel, Chiralcel OD-H) was used to determine the ee % of the
product by HPLC. The chiral column is commercially available and made by
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immobilizing a single enantiomer, cellulose tris(3,5-dimethylphenyl carbamate), onto the
stationary phase (Figure 5.4). The separation of allylic substitution enantiomers is based
on the interaction of each enantiomer with the cellulose tris(3,5-dimethylphenyl
carbamate) in the stationary phase in which one enantiomer will be retained in the
column longer than the other.

silica-gel

Figure 5.4 Cellulose tris (3,5-dimethylphenyl-carbamate) coated on silica-gel

The palladium complexes of ligands (S,S)~oxa-a(+), (rac)-oxa-4-MeO, (+)-oxa4-MeO, C 2 (RRRR), and C 2 (RSSR) catalyzed allylic substitution reactions. The
products were isolated in good yield (80-86%); however, there was no enantioselectivity.
No asymmetric induction was relayed through the palladium-ligand complex to afford the
stereoselective substitution. The difference ee% analysis’s results between shift reagent
and HPLC method (Table 5.1, entry 3-5), which could be explained that the substitution
product NMR sample was contaminated with some impurities that might affect the
methyl’s proton peaks. Additionally, it could be error from integration in NMR spectrum.
Comparison X-Ray analysis of 4-MeO-benzyl-L and 4-MeO-benzyl-Pd-OTf showed
the dihedral angle (N-C-C-N) was changed to smaller angle (8.6°), therefore ligand could
not created steric hindrance or electronic effect at the catalytic site to cause asymmetric
induction affect (Figure 5.5).
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Figure 5.5 ORTEP representation of 4-MeO-benzyl L (left) and
4-MeO-benzyl-Pd-OTf (right)

As an extension of this investigation, asymmetric allylic amination of 1,3diphenylprop-3-en-l-yl acetate with benzylamine was also carried out. Allylic amination
with allylic acetates has been used in the synthesis of carbocyclic nucleoside such as
carbovir, an in vitro inhibitor of the HIV virus (Scheme 5.4),11 using Pd(PPh3 ) 4 as metal
source.

O

P d (P P h 3)4

carbovir

Scheme 5.4 Palladium-mediated reactions used in the synthesis of Carbovir

During the past decades many studies have focused on efficient chiral catalysts.
Among them, the ligand developed by Togni,12 Hayashi and Ito,13 and Helmchen and
Pfaltz14 has proven to be very effective in allylic amination reactions (Scheme 5.5).
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OA c
Ph

NHBn
Pd(OVLiqand
BnNH2

Ph
OH

C p2Ru

Togni

Yield = 90%
99 % e.e.

Ph

OH

Hayashi and Ito

Yield = 93%
97 % e.e.

PPh2

Helmchen and Pfaltz

Yield = 98%
94 % e.e.

Scheme 5.5 Ligands for allylic amination reactions

We applied phenanthroline ligands to the palladium-catalyzed allylic amination of
(£)-l,3-diphenylpro-2-enyl acetate with benzylamine in tetrahydrofuran (THF). The
catalyst was prepared in situ by mixing 2.5 mol% Pd(dba) 3 and 5 mol% ligands (rac)oxa-4-MeO, 4-Et-anilyl, benzyl L, and (rac)-a(+) L under an argon atmosphere.
Unfortunately, conversions were low (< 10%).

Based on the results reported above, there is a possibility that these ligands will
find future applications. Catalysis results may be improved by modifying the 2- or/and Im
position, which would possibly amplify the helical twist. This amplification may be
necessary to better relay stereochemical information from the B-ring.
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CHAPTER 6: PALLADIUM CATALYZED AMINOHALOGENATION

Vicinal haloamine compounds are very important intermediates for organic and
medicinal chemistry. They can be transformed into aziridines or P-substituted amino
acids.1,2 Recently, Guigen Li’s group has done several studies of the heterolytic additions
of nitrogen

and

halogen

atom

-5 Q

to

olefins, '

and

transition

metal-catalyzed

aminohalogenation of cinnamic esters is one methodology that interested us. Li6 reported
the use of metal-ligand complexes as the catalysts in the aminohalogenation of a,punsaturated carboxylic esters. Out of eight different metal complexes Li found dichlorol,10-phenanthroline-palladium(II) was the only metal complex that carried out the
reaction to completion in 81% yield. The reactions were performed by simply combining
of cinnamic esters (olefin substrates), N,N-dichloro-IpI-toluenesulfonamide (TsNCk, or
dicholoramine T) as nitrogen and chlorine sources, and dichloro-1,1O-phenanthrolinepalladium(II) in acetonitrile at ambient atmosphere (Scheme 6.1).

N
ph/ ^ C O O M e

1 T s N C I 2,

N

C |> d ^ c [ (8 mol% )

2. N a2S 0 3

^ J ^ C O O M e
NHT s
(±) (81% )

Scheme 6.1 Aminochlorination of cinnamic ester with Pd-l,10-phenanthroline complex6
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Li’s aminohalogenation reactions were reported with > 95% regio- and
stereoselectivity in most case. iV-iV-Dichlorosulfonamide reacts with the olefin to form an
A-chloroaziridinium intermediate and the palladium metal center of metal complex
coordinates to the chlorine atom of TsNCL which weakens the N-Cl bond and C f leaves
to form the “Ts-N8+-C1” species. The Pd-associated chlorine anion then acts as
nucleophile to open the /f-tosyl-TV-chloro aziridium intermediate.3,4’6The Sn2 mechanism
of aziridinium ring opening is accountable for the anti seteroselectivity. And because the
stabilization effect of the phenyl ring, the p-carbon of the aziridinium ring has a more
positive charge than the a-carbon, therefore controlling the regioselectivity of the
reaction (Scheme 6.2).

Cl

--C l

Tsy
SV

*,

COoMe

Cl

NCITs

NHTs

Scheme 6.2 Proposed mechanism of aminohalogenation reaction

The regioisomers were distinguished by their *H NMR spectra in which the
coupling constants and correlation patterns in the HMBC spectrum (Heteronuclear
Multiple Bond Correlation) clearly showed their structural differences. Sudalai reported10
a proton resonance for aminobromination reactions that help explain the regiochemistry.
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In general, the a proton appears more upfield in comparison to the P proton. Moreover,
the multiplicity of each methine proton changes depending on the adjacent substituent
(Figure 6.1). For ethyl ester 4a, the a proton is adjacent to the bromine and gives a
doublet peak. However, in methyl ester 3a, the a proton is attached to the carbon with the
/7-toluenesulfonamido group and couples with the NH, thus yielding a doublet of doublet
peak.

T

T

*r

Tj

1.72 M3T
8,0

7.9

7a

t£

6 .0

5.5

5,0

4 .S

4 .0

£8

SO

&

2 0

IS

1v

o !s

Figure 6.1 *H NMR spectra of aminobromination products reported by Sudalai10
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aS5

To investigate whether our ligands could catalyze in aminohalogenation reactions,
we applied (rac)-oxa-4-Et-anilyl-PdCl2, (rac) and (+)-oxa-4-MeO-PdCl2, and (S,S)-oxaa(+)-PdCl2 complexes as catalyst. Following the literature procedure as shown in
Scheme 6.1,6 the methyl cinnamate (1.0 equiv) reacted with TsNCk (1.2 equiv) in
acetonitrile in the presence of ligand-palladium complexes (8 mol%). Upon completed
conversion, the crude mixture was reduced with a Na2 S0 3 solution. After regular workup
and purification with SiC>2 chromatography, we obtained an unknown major product (3038% yield), which is likely analogous to the aminohalogenation product reported by Li,
trans-methyl

3-chloro-3-phenyl-2-(tosylamino)propanoate.

We

speculate that the

unknown could be one of the syn- aminohalogenated product based on comparison with
'fl NMR spectra (/vicinal); vicinal protons decreased from 10.3 to 2.93 Hz. The 13C NMR
spectrum showed 4 sp3 and 13 sp2 carbons; the GCMS showed the molecular mass of
M+l (369). We also obtained an inseparable mixture o f vicinal haloamine derivatives.

Under modified reaction conditions, the methyl cinnamate (1.0 equiv) reacted
with TsNCb (1.2 equiv) in the presence of the (5,)5)-oxa-a(+)-palladium complex, which
was generated in situ from (S,S)-oxa-a(+) ligand (10 mol%) and allylpalladium chloride
dimer (2.5 mol%). The reaction successfully produced the trans-methyl 3-chloro-3phenyl-2-(tosylamino) propanoate product in good regio- and stereoselectivity (19:1) in
dry DCM as solvent (Scheme 3). Contrary to Li’s report there was no control in regioand stereoselectivity when MeCN was employed. The enantiomeric excess of trans-
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methyl 3-chloro-3-phenyl-2-(tosylamino)propanoate was determined to be 4% by chiral
HPLC analysis on a Chiralcel OD-H column.
Cl
ph/

^

COOM e

1 ■T s NCI2, [Pd(r13-C 3H 5)CI2]/ L*
2.

N a2S 0 3

phA ^ C O O M e
NHTs

Ph
*

Scheme 6.3 (1S',5)-oxa-a(+)-Pd-eatalyzed aminochlorination
of methyl cinnamate
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CHAPTER 7: REDUCTION OF ACETOPHENONE WITH TRI-ETHOXYSILANE, (EtO)3SiH

The enantioselective reduction of prochiral ketones to optically active secondary
alcohols remains a pivotal transformation in organic synthesis and the use of chiral metal
complexes as catalysts is an ideal method. Asymmetric hydrosilylation has been known
since the early 1970s by using nickel-coordinated chiral phosphines,1 and later the most
efficient catalyst was developed with ruthenium catalysts coordinated to chiral
diamines.2,3 Mimoun and co-workers4 have recently accomplished the enantioselective
hydrosilylation of ketones in the presence of a chiral diamine zinc catalyst and
polymethylhydrosiloxane (PMHS) as hydrosilylating reagent. Subsequently hydrolysis of
the silyl ether product gave the desired secondary alcohols (Scheme 7.1).

Ri \ & h
O

H
+

Ri^ R 2

Z nE t2 (2 mol% )
chiral d iam in e (2mol% )

-S i-O Me

?

OH-

-S i-O T o lu en e, 2 5 °C

. Me

n

OH

R ^R 2

Scheme 7.1 ZnEt2 mediated reduction of carbonyl compounds

According to Mimoun,4 catalytic activity can only be achieved when both a chiral
diamine and ZnEt2 are employed. ZnEt2 coordinates ligands such as diamines and forms
monomeric tetrahedral complexes. The author proposed a mechanism (Scheme 7.2) in
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which the ZnEt2-diamine complex reacts with the carbonyl compound to form the sevenmembered intermediate during the reduction with PMHS to give silyl ether.
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Scheme 7.2 Reduction of carbonyl compounds by chiral diamines and ZnEt2

In order to explore application for our novel C2 diamines, we employed (5S,6S)and

(5R,6R)-5,6-dihydro-N5,N6-bis((i?)-l-phenylethyl)-l,10-phenan-throline-5,6-

diamines in the enantioselective reduction of acetophenone with tri-ethoxy-silane and
Zn(II). Following the literature procedure.5 Acetophenone was treated with 5 mol% of
diethylzinc (l.OM in hexanes), and 5 mol% of the chiral ligand in freshly distilled toluene
at ambient temperature in the presence of 1.2-1.5 eq. of (EtO)3SiH for 18 h. The reaction
was monitored by TLC, the silyl ether product purified by column chromatography on
silica gel and subsequently hydrolyzed with aqueous KF solution in methanol to give the
desired alcohol, 1-phenyl-1-ethanol (Scheme 7.3). The product was characterized by 1H,
13C NMR spectroscopy, and the enantiomeric purity of 1-phenyl-1-ethanol was assessed
by HPLC on a chiralcel OD-H column. The HPLC spectra’s area peaks for each alcohol
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enantiomer were used to calculate enantiomeric excess. The pure commercial (R)-(+)-lphenyl-1-ethanol alcohol was injected in the HPLC system to use as a reference standard
and to assign the product configuration. The results are summarized in Table 7.1.

OSi(OEt)3
1. ZnEt2, L*
Toluene, r.t
2. (EtO)3SiH

A

B

C

D (-)

E(+)

Scheme 7.3 1,10-phenanthroline ligands and ZnEt2 catalyzed
reduction of acetophenone with (EtO^SiH

Chiral amino alcohol ligands were also tested for this reaction. Similar to C2
diamines, amino alcohol ligands complexed with ZnEt2 upon addition of acetophenone
and (EtOjaSiH (Scheme 7.3) but with only low stereoselectivity (Table 7.1).
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Table 7.1 Enantioselective reduction of acetophenone in the presence of diethylzinc and
a chiral ligand

Chiral ligand

Reaction time (h)

Yield (%)

ee(%)

A

24

88

17 (R)

B

24

97

22 (5)

C

24

66

5 (5)

D (-)

24

74

8 (5)

E (+)

24

64

6 (5)

Chiral 1,10-phenanthroline ligands gave conversion of up to 97 % isolated yield
(B ligand). However the enantioselectivity was very low. A possible explanation for this
could be ZnEt2 activation. Mimoun et a l 4 reported that chiral diimines can also activate
ZnEt2 to catalyze the reaction (Figure 7.1).

95% 75(S)

97% 74(S)

98% 72(S)

95% 70(S)

98% 73(S)

Figure 7.1 Reported ZnEt2 activated-diimines

As seen in Table 7.1, chiral diamines give very good isolated yields (88-97%) and
the highest enantioselectivity (17 and 22 % ee). In comparison amino alcohols give lower
yields (64-74%) and almost no new stereoselectivity (5-8% ee). It can be explained by
the bond strength of the Si-0 versus the Zn-O, as reported by Mimoun.4 The amino
alcohol reacts with ZnEt2 to form a dimeric-zinc complex which subsequently reacts with
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the ketone substrate and reducing agent, (EtO^SiH, to produce a silyl ether. The latter
was isolated by Mimoun. However, because the electron affinity of the Si-0 bond
(covalent) is higher than Zn-0 bond (ionic), after addition of (EtO^SiH in the second
step the dimeric-zinc complex can react with the reducing agent to generate EtZnH and
the corresponding silyl ether. The reaction between the dimeric-zinc complex and
(EtO)3 SiH results in a reduced catalyst lifetime that is responsible for low yields for the
reduction of acetophenone. We suspect that amino alcohol ligands form similar silyl
ethers as seen in Scheme 7.4.

(EtO)3 Si—O
2 (EtO)3SiH

» 2 Zn(Et)H

N

+

Scheme 7.4 Likely reaction of dimeric-zinc complex with (EtO^SiH reagent
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CHAPTER 8: ZINC CATALYZED DIRECT ALDOL REACTION

The aldol reaction, the simple addition of an enolate donor to a carbonyl acceptor,
is one of the most fundamental tools for the construction of new carbon-carbon bonds in
organic synthesis. It is a useful method for preparing P-hydroxy carbonyl compounds.
The ability to control the newly formed stereogenic centers is very important for the
synthesis of natural products. In general, control of stereochemistry has been achieved by
either the use of chiral aldehyde substrates or of stoichiometric chiral auxiliaries attached
to the enolate donor. However, the preconversion of the ketone moiety to a more reactive
species such as silyl enol ethers or enol methyl ethers is typically required of these
asymmetric aldol reactions (Scheme 8.1).

O
^ R

S iR 3
1

3

O

Chjra | ca ta ly st

"

r 2c h o

^
"

R2" ^ " R

1

Scheme 8.1 Mukaiyama-type reaction

Watanabe reported the aldol reaction of p-nitrobenzaldehyde with acetone
catalyzed by Zn2+ complexes of a-amino acid esters in 1985, and these mild reaction
conditions afforded the aldol products along with some dehydrated aldol product
(Scheme 8.2).1
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OH
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O oN

O oN
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Scheme 8.2 Zn(II) catalyzed aldol reaction (Watanabe)

The Watanabe aldol reaction scheme has given an entry point into the direct aldol
reaction. In 1999, Shibasaki et a l2 developed a direct asymmetric aldol reaction in which
unmodified ketones directly react with aldehydes using a chiral metal complex in
catalytic amounts (LaLi3 -trisbinaphthoxide, LLB). This catalyst behaved like a DAHPaldolase enzyme (Scheme 3),3 affording aldol products of up to 94% ee.

The aldolase mechanism is believed to involve cocatalysis by the function of a
Zn2+ ion as a Lewis acid and a basic functional group in the enzyme’s active site.
Therefore, aldolases can be thought of as multifunctional catalysts exhibiting Lewis
acidity and Br0nsted basicity.

T ype II ald o lase
H's

His

Scheme 8.3 Type II aldolase mechanism4
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The catalytic cycle of the Shibasaki’s asymmetric aldol reaction is shown in
Scheme 8.4 The Bronsted base functionality (OM) in the heterobimetallic asymmetric
catalyst (I) is proposed to abstract an a-proton from a ketone to generate the metal
enolate (II). In the meantime the Lewis acid functionality (LA) activates the aldehyde
component to yield complex (III), which can then react in a chelation-controlled
asymmetric environment to afford a P-keto metal alkoxide (IV). Proton exchange
between the metal alkoxide moiety and a proton source could then regenerate the catalyst
(I) and liberate an optically active aldol product (Scheme 8.4).2
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O

-C

l

,

O

v

a
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O -L A
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\
/

LA: Lewis acid
M : Metal of B ronsted b ase
r

R1

O — LA*

0

*(

: chiral ligand

o

IV

Scheme 8.4 Catalytic cycle of direct catalytic asymmetric aldol reactions2

Recently, Michael A. Calter reported5 an approach that is similar to the type II
aldolase and the Watanabe aldol reaction method in which the bifunctional amine-zinc
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catalysts containing Lewis acid and basic functionalities, were used to perform the direct
aldol

reaction.

Particularly

the

zinc-(15',25)-tetramethylcyclo-hexane-1,2-diamine

complex, which was generated in situ by the reaction of (l<S,25)-tetramethylcyclohexane1,2-diamine (20 mol%) with Zn(N03)2 (10 mol%) in methanol, catalyzed the aldol
reaction of acetone (5.0 equiv.) and p-nitrobenzaldehyde (1.0 equiv.) to produce only one
aldol product. 4-Hydroxy-4-(4-nitrophenyl)butan-2-one was isolated in 37% yield and
22% enantiomeric excess (Scheme 8.5).

0

J]
Me

+
Me

o

IT

H ^A r

MeoN

10 m ol% Z n (N 0 3)2
20 mol% L*
. . oul . . . .
"
M eOH, rt, 24h
Ar = p - N 0 2P h

o

IT

OH

i*

M e ^ ^ ^ A r
37% iso lated yield
22% e e

N M e,

Scheme 8.5 Direct aldol reaction with zinc-diamines complex5

Based on Calter’s report5 we investigated our C2 diamine-1,10-phenanthroline
ligands in the direct aldol reaction of acetone and /?-nitrobenzaldehyde. The reaction was
carried out in the presence of C2 diamine ligand or Lewis acid alone, neither reaction
showed conversion. However, when we used a combination of C2 ligand (20 mol %) and
Lewis acid (10 mol %), likely forming a bifunctional catalyst, the reaction produced the
aldol product (Scheme 8.6). Several Lewis acids were used to test the reaction such as
Zn(N03)2.6H20 , Zn(OTf)2, ZnCl2, Sn(OTf)2, N i(N 03)2.6H20 , Cu(OTf)2.
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—N

OH
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Ph

—N
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C 2 (RSSR)

C 2 (RRRR)

Scheme 8.6 Direct aldol reaction with diamine- 1,10-phenanthroline complexes

Among the screened Lewis acids, we found that only Zn(NC>3)2.6H20 and
Zn(OTf)2 could react with C2-diamine ligands to form a catalyst for the direct aldol
reaction in 47% and 8% yield, respectively. We also found some dehydrated aldol
product as a by-product when Zn(OTf)2 was used. The investigation was then focused on
the use of Zn(N 0 3 )2 .6 H2 0 as Lewis acid with C2-diamine ligands for the direct aldol
reaction to optimize the conditions. There was no temperature and solvent effect when
the reactions were conducted in MeOH, MeCN or a room temperature to 40°C. The
Lewis acid to ligand ratios (10:20, 20:20, and 30:20 mol%) was also studied. The best
yields (30-47%) of the aldol product 4-hydroxy-4-(4-nitrophenyl)butan-2-one was
observed with 10 mol% Lewis acid and 20 mol% C2-diamine ligands. The enantiomeric
excess of 4-hydroxy-4-(4-nitrophenyl)butan-2-one was determined to be 99% by chiral
HPLC analysis on Chiralcel OD-H column. The results are summarized in Table 8.1.
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Table 8.1 Chiral diamine ligands for direct aldol reaction with Zn(NC>3 )2
Ligand

Zn2+/ligand ratio (mol%)

Time (h)

Isolated yield (%)

ee (%)

C2 (RRRR)

5:10 mol%

48

47

99 (R)

C2 (RRRR)

20:20 mol%

48

29

99 (R)

C2 (RRRR)

30:20 mol%

48

25

99 (R)

C2 (RSSR)

10:20 mol%

48

39

99(5)

C2 (RSSR)

20:20 mol%

48

24

99(5)

Because the reaction yields were low to moderate we tried to apply an alternative
method that was published by Nakadai.6 They replaced the Lewis acid with protonic acid
for the direct aldol reaction of p-nitrobenzaldehyde with acetone using a mixture of chiral
diamine-protonic acid (10 mol%, 1:1 ratio) as catalyst. A plausible mechanism of the
catalytic pathway to aldol adducts involves the interaction of the amine with acetone to
form the corresponding enamine after dehydration. The next step involved a sixmembered chair-like transition state in which the aldehyde’s aromatic ring adopted a
pseudoequatorial position to yield the aldol product (Scheme 8.7).
o

H

■HX

Ar.

ArCHO

' Ns

r

-HoO

R' N\"^ ©NH rx

H0

R ©

' h-

H

OH

- Diamine ■HX

n

...R
N'
I
R

+H20

xe

1

R

plausible transition state

Scheme 8.7 Mechanism for the diamine-catalyzed aldol reaction
proposed by Nakaida6
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Ar

O

Following the

literature procedure, 6

we used a mixture of trifluoro-

methanesulfonic acid (triflic acid, CF 3 SO 3 H) as protonic acid (10 mol%) with C2diamine-l,1 0 -phenanthroline ligand

(1 0

mol%) to catalyze the direct aldol reaction o fp-

nitrobenzaldehyde in acetone. Unfortunately, the reactions were deactivated after 4 days
under argon atmosphere at 40-50°C. The acidic and basic functions of triflic acid and
diamine are likely incompatible. Possibly the enamine intermediate, which derived from
the C2 -diamine-triflic acid adduct and acetone, could not form a six-member chair-like
transition state with /?-nitrobenzaldehyde or it could react with p-n itrobenzaldehyde and
the resulting ammonium intermediate inactive to acetone. Furthermore, triflic acid could
protonate the C2 ligand at the diimine moiety, which could prevent the formation of a sixmember chair-like transition state.

Finally, Calter’s reaction conditions with addition of a small amount of Et3 N,
gave the product in good yield (76%) but without changing enantioselectivity previously
observed. A small amount of dehydrate by-product was also produced (less than 3%).
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CHAPTER 9: PRELIMINARY STUDIES OF CATALYTIC MICHAEL
ADDITION REACTION

The Michael addition reaction involves the addition of a carbanion nucleophile to
a,p-unsaturated systems. Carbon-carbon bond formation via Michael additions are most
frequently performed under basic conditions, however, this method suffers from side
reaction such as aldol-cyclization products. The conjugate addition of 1,3-dicarbonyl
compounds to enones such as methyl vinyl ketone (MVK) can be catalyzed by metal
complexes and also allows asymmetric catalysis with chiral ligands. The cobalt-catalyzed
Michael addition of methyl-l-oxo-2-indanecarboxylate to MVK was first reported by
Brunner and Hammer (Scheme 9.1) . 1 In the presence of (1 S,2S)-(-)-1,2-diphenylethylene
diamines as chiral ligand the Michael product was formed with 6 6 % enantiomeric excess.

C o (a c a c )2

Scheme 9.1 Michael addition with diamine-cobalt complex

Recently, Christoffers et al.2 reported the addition of ethyl 2-oxocyclohexanecarboxylate to MVK using (i?,7?)-tram-l,2-diamino-cyclohexane. The reaction was
conducted under aerobic conditions, at ambient temperature with an enantioselectivity of
up to 91% ee (Scheme 9.2).
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49%, ee % (not yet determine)

Scheme 9.2 Michael addition with diamine-nickel complex, comparison o f
Christoffers’ work and our result

We

conducted

preliminary

studies

for

the

addition

of

ethyl

2-

oxocyclohexanecarboxylate to MVK in the presence o f our chiral C 2 diamine-1,10phenanthroline ligand and nickel salt. The C 2 (RRRR) diamine-1,10-phenanthrolinenickel complex was generated in situ and catalyzed the Michael addition reaction under
aerobic conditions at ambient temperature. The Michael product formed in 49% yield and
was confirmed by ^

13C NMR, and IR spectroscopy.
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CHAPTER 10: SUMMARY AND OUTLOOK

Organometallic catalysis is a rapidly growing area in synthetic chemistry. In this
research project we have demonstrated new conditions to prepare high quality

,

1 10

-

phenanthroline epoxide in good yield and high purity. We also prepared new 1,10phenanthroline derivatives (5,6-aminoalcohol, 5,6-oxazolidinone, and C2 symmetrically
diamine-1 , 1 0 -phenanthro-line) using 1 , 1 0 -phenanthroline epoxide as a key intermediate.
The introduction of stereogenic centers in the B-ring was achieved by nucleophilic ring
opening of 1,10-phenanthroline epoxide in the presence of Lewis acid, Mg(C 1 0 4 )2 . The
chiral aminoalcohol derivatives were produced in good yield (62-97%). NMR
spectroscopy, X-ray analysis and computational analysis have been applied to investigate
conformational preferences of the new 1,10-phenanthroline derivatives. The interchange
of 5- and 6 -subtituents between pseudoaxial (anti) and equatorial positions (syn) alters
the ligand twist that affects the ligand chelation site (NCCN). Cyclization of 5,6aminoalcohol-1 , 1 0 -phenanthroline derivatives, obtained through carbonylation with
triphosgene, permanently locked the 5- and 6 -subtituents in the syn conformation. The
complexation of 1 , 1 0 -phenanthroline derivatives with transition metals was investigated
to test their coordination capabilities. We screened several ligand applications. Metalcatalyzed reactions included allylic substitution, aminohalogenation, direct aldol, and
ketone reduction. So far, our research showed that 5,6-oxazolidinone ligands can catalyze
allylic substitution of rac-(£)-l,3-diphenyl-2-propenyl acetate with dimethyl malonate in
good

yield

(80-86%),

however,

without

asymmetric

induction

affects.

The

allylpalladium-oxazolidinone-chloride complex can also catalyze chloroamination of
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methyl cinanamate with good control of regio- and stereoselectivity but further studies
are needed to improve yields and test enantioselectivity. C2 -symmetrical diamine-1,10phenanthroline ligands gave good performance for the direct aldol reaction of pnitrobenzaldehyde with acetone. As proposed the C 2 diamine-zinc complex served as a
bifunctional catalyst for the formation of the aldol product with 99% ee in good yield
(76%). The reduction of acetophenone was accomplished in good yields (88-97%) but
low ee when using C2 diamine ligands.

Additional work showed that the complexes of Pd-(±)-oxa-4-MeO, (-)-oxa-4MeO, (5',5)-oxa-a(+), C 2 (RRRR), and C 2 (RSSR)) promote allylic substitution
reactions. However, there was no asymmetric induction and racemic mixtures were
isolated. It is likely that coordination of the ligand to the metal overrides the dihedral
angle (N-C-C-N). Therefore, the attachment of a group (R) replacing hydrogen at either
the 2- and/or 9- position may be needed to amplify the effect of the B-ring stereocenters,
thus improving stereocontrol. The new ligand template in Scheme 10.1 could be
described as a mix of template la and III (page 9).

x

y

x

y

M etal coordination
N

N
M

Scheme 10.1 Complexation of phenanthroline with substituents in the 2- and 9- position
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Additional derivatives like 2,9- and 5,6-tetrasubstituted phenanthrolines were
prepared in the same manner as 5,6 -disubstituted-1,10-phenanthroline as outlined in
Scheme 10.2.

NaOCI, pH 8.6
=N
R

N= ^

PTC, CHCI3

R'NH,
Mg(CI04)2 /MeCN

•=N

reflux 80°C

R

~ N'
R

N:
(rac)

R

PTC = tetrabutylam m onium hydrogen sulfate

HQ

NHR'

HQ

NHR'

R = -CH3

resolution

s P h3

+

N

N

-i-C
N—

OMe

Ph

Scheme 10.2 Preparation o f 2,9-disubstituted-5,6-aminoalcohol1 , 1 0 -phenanthroline derivatives

The

2,9-dimethyl-l,10-phenanthroline-5,6 -epoxide

(2,9-phen-epoxide)

was

successfully prepared by oxidizing 2 ,9-dimethyl-1 , 1 0 -phenanthroline, with commercial
bleach (NaOCI) in the presence of a phase transfer catalyst (PTC) in chloroform. After
purification by silica gel chromatography, 2,9-phen-epoxide was obtained in good yield
(78%).
The epoxide ring opening of 2,9-phen-epoxide with different amine nucleophiles
was achieved under refluxing conditions in acetonitrile in the presence of Mg(C 1 0 4 )2 .
The diastereoisomeric (5R,6R) and (5S,6£)-6-((i?)-l-phenylethyl-amino)-5,6-dihydro-2,9-

103

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

dimethyl-l,10-phenanthroline-5-ol mixture product, (2,9-diMe-a(+)-L), and racemic 6 (4-methoxybenzylamino)-5,6dihydro-2,9-dimethyl-l,10-phenanthroline-5-ol, (2,9-diMe(4-MeO-benzyl)-L), were obtained when using a(+)-methylbenzylamine and pmethoxybenzylamine as nucleophiles, respectively.

So far, we have been unable to separate the stereoisomers of 2,9-diMe-a(+)-L by
column chromatography or recrystallization. Unfortunately, resolution attempts of the
2,9-diMe-a(+)-L mixture with chiral acid such as S-mandelic, S-tartaric, and Dcamphoric acid were also unsuccessful. We anticipated that the diastereomeric salts
would have different property in solubility, which then can be separated from each other.

The 2,9-diMe-a(+)-L mixture was converted to the corresponding copper
complexes through coordination with copper sulfate. The diastereoisomeric complexes
could also not be separated. Additional research is necessary to develop the 2,9substituted phenanthroline template.

One approach could involve reactions with bulky chiral acids to facilitate
diastereomeric salt crystallization. Alternatively, one could convert the 2,9-diubstituted
aminoalcohols into 2,9-disubstituted 5,6-oxazolidinone derivatives and test the resolution
at that stage.

For the reduction of acetophenone, we suspect that the low ee was due to
competing chelation of ZnEt2 between the diamine and diimine. To corroborate this and
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to improve enantioselectivity one could convert the diimine into a diiminium moiety
(Scheme 10.3).

y —NH HN—\
Ph
>— (
Ph

B r^ ^ ^ B r

Ph'

Toluene, heat reflux
N

N=

-NH HN—\
>— (
Ph

-N
Br\

©

NJ Br

©

Scheme 10.3 Proposed preparation of C2 diamonium-diamine ligand

The new C2 diamonium-diamine ligand could be tested with Carpentier’s new
method, 1 involving direct ketones reduction to alcohols with polymethylhydro-siloxane
(PMHS) in the presence of ZnEt2 and 1,2-diamine ligand in a one step procedure.

We also conducted preliminary studies for the Michael addition reaction which
showed that C2-diamine ligands with Ni(OAc)2 .4 H2 0 catalyzed the formation of the
Michael

adduct product.

Additional

optimization

of reaction

conditions

enantioselectivity is needed.
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APPENDIX A
EXPERIMENTAL SECTION
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EXPERIMENTAL SECTION

Reagents and Solvents
All reagents and solvents used in this research project were purchased from
Acros, Lancaster, Aldrich or TCI Chemical Companies. Chemicals were more than 99%
purity and were used without further purification. All commercial solvents used were of
reagent grade. Dichloromethane was dried by distillation from P2 O5 before use. Silica gel
(32 - 63 mesh, Dynamic Absorbents, LLC) was used for column chromatography. Silica
and alumina TLC plates (UV/254) were purchased from AllTech.

Characterization of Compounds and Instrumentation

'fl NMR spectra were recorded with at 400 MHz and 13C NMR spectra were
obtained with a 100 MHz JEOL Eclipse nuclear magnetic resonance spectrometer, with
tetramethylsilane (TMS) as an internal standard. Chemical shifts are given as

8

values

(ppm) and coupling constants J are given in Hz. Melting points were taken using a
Thomas-Hoover Unimelt instrument and reported in degree Celcius. FT-IR spectra were
recorded on a Bruker Equinox 55 and Perkin Elmer 1710 Fourier Transform Infrared
Spectrometers. Optical rotations

[ oc] d

were measured at 20°C in a 1.0 dm cell, using a

Perkin-Elmer 341 spectrophotometer. The enantiomeric excess (ee) was determined by
HPLC analysis, performed on a Waters HPLC system consisting of the following: 515
HPLC pump, 2487 Dual X Absorbance Detector, measured at 254 nm; column DAICEL
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CHIRALPAK OD-H (250 x 4.6 mm); mobile phase, hexane/2-propanol. NuMega
Resonance Labs, Inc., San Diego, CA, performed microanalyses.

— N

N—

1,10-Phenanth roline-5,6-epoxide, (Phen-oxide)
To mechanically stirred commercial bleach (6 %, 100 mL), adjusted to pH

8 .6

with concentrated sulfuric acid, was added a mixture of tetrabutylammonium hydrogen
sulfate (1.8 g, 5.3 mmol, 0.5 eq.) and phenanthroline monohydrate (2.0 g, 11 mmol, 1.0
eq.) dissolved in chloroform (20 ml). The reaction mixture was agitated vigorously at
room temperature for 15-30 min, depending on the quality of bleach. After the reaction
was complete as observed by reverse phase TLC, the organic layer was separated and the
aqueous layer was extracted with chloroform (3 x 25 mL). The combined organic layers
were washed with several portions of water and brine, dried over anhydrous sodium
sulfate, filtered, and the solvent removed in vacuo to yield the light yellow compound
(1.75 -1.85 g, 80-85%). The crude epoxide was purified by recrystalization from
chloroform and hexanes to give pure product (50-75%). 'H NMR (400 MHz, CDCI3 ) 5
8.91 (2H, d, J = 4.76 Hz), 8.02 (2H, d, J = 7.69 Hz), 7.41 (2H, dd, J = 4.76, 7.69 Hz),
4.62 (s, 1H); 13C NMR (100 MHz, CDC13) 5 151.0, 149.6, 138.4, 129.2, 123.9, 55.4;
(m.p. 163 °C; lit. m.p. 165°C).
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)= N
Me

N~
Me

2,9-Dimethyl-l,10-phenanthroline-5,6-epoxide, (2,9-Phen-epoxide)
Commercially available bleach (NaOCl, 46 mL) was adjusted to pH

8 .6

with

conc. sulfuric acid. To this solution was added a mixture of (1.0 g, 4.61 mmol) of 2,9dimethyl-l,10-phenanthroline and (0.781 g, 2.3 mmol) tetrabutylammonium hydrogen
sulfate (PTC) in chloroform (10 mL). The biphasic mixture was stirred at room
temperature for about lhr. After the conversion was completed the layers were separated
and the aqueous layer extracted with CHCI3 (3 x 10 mL). The combined organic layer
was washed with water and brine and dried over anhydrous Na 2 S0 4. Filtration and
evaporation gave the crude product. The crude epoxide was purified by silica gel
chromatography (CHCls/5% MeOH) and yielded the pure product (0.8 lg), (m.p. 184°C)
in 78% yield. *H NMR (400 MHz, CDC13) 5 7.85 (2H, d, J = 7.69 Hz), 7.23 (2H, d, J =
7.69 Hz), 4.56 (2H, s), 2.74(6H, s); 13C NMR (100 MHz, CDC13) 5 160.3, 149.1, 138.7,
126.6, 123.7, 55.5, 25.3; FT-IR (NaCl, DCM solution) v/cm-1 3029, 2964, 2925, 1570,
1482, 1456, 1398, 1140, 822, 735; Anal Calcd for Ci4 H, 2 N 2 0 . V2 H20: C, 72.09; H, 5.62;
N, 12.01. Found C, 72.4; H, 5.81; N, 12.21.

G en era l P ro ce d u re f o r ep o x id e o p e n in g w ith M g (C l 0 4 )2

l,10-phenanthroline-5,6 -epoxide (500 mg, 2.5 mmol) and Mg(C104 ) 2 (850 mg,
3.8 mmol) were dissolved in CH 3 CN (10 mL) and the solution was heated at 40°C for 20
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minutes, followed by the addition of the amine nucleophile (1.1-1.5 eq.). The reaction
mixture was stirred and heated at 80°C for 24-72 hrs while monitored by TLC (AI2 O3 ,
CHCl3 / 5 % MeOH). Upon completion, the reaction was quenched with water and the
crude material was washed with hexanes to remove excess nucleophile. The aqueous
layer was extracted with chloroform and the combined organic layer washed with water
and brine. Drying with anhydrous Na2 SC>4 , followed by filtration and concentration gave
the crude material.

HO

HN

■=N

tra«5-5,6-Dihydro-6-anilylamino-l,10-phenanthroline-5-ol, (anilyl adduct)
Purification by crystallization from CHCU/Hexanes yielded a solid (m.p. 210°C)
in

8 6

% yield. !H NMR (400 MHz, CDC13) 5 8.7 (2H, dd, J = 4.76, 4.76 Hz), 8.07 (1H, d,

J = 7.69 Hz), 7.79 (1H, d, J = 7.69 Hz), 7.36 (1H, dd, J = 4.76, 7.69 Hz), 7.26 (1H, dd, J =
4.76, 7.69 Hz), 7.17 (2H, t, J = 7.32, 8.06 Hz), 6.77 (1H, t, J = 7.69, 6.96 Hz), 6.70 (2H,
d, J = 7.69 Hz), 5.08 (1H, d, J = 10.62 Hz), 4.82 (1H, d, J = 10.62 Hz); 13C NMR (100
MHz, CDCI3 ) 5 150.18, 150.11, 149.64, 147.10, 135.00, 134.17, 134.10, 133.10, 129.81,
124.42, 124.29, 119.19, 113.83, 70.54, 58.62; FT-IR (NaCl, DCM solution) v/cm-1 3054,
2923, 2851, 1601, 1498, 1419, 1263, 1077, 797, 746, 694.
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fr«/is-5,6-Dihydro-6-benzylamino-l,10-phenanthroline-5-ol, (benzyl adduct)
Purification by column chromatography (SiC>2 , CHCl3/5% MeOH) yielded a solid
in 87% yield. *H NMR (400 MHz, CDC13) 5 8.66 (1H, d, J = 4.76 Hz), 8.65 (1H, d, J =
4.76 Hz), 7.90 (1H, d, J = 6.96 Hz), 7.80 (1H, d, J = 7.32 Hz), 7.27-7.34 (m, 7H), 4.87
(1H, d, J = 9.15 Hz), 4.03 (1H, d, J = 9.15 Hz), 4.02 (1H, d, J = 13.18 Hz), 3.87 (1H, d, J
= 13.18 Hz); 13C NMR (100 MHz, CDC13) 8 150.9, 149.9, 149.7, 149.6, 139.4 134.8,
134.4, 133.2, 128.7, 128.2, 127.6, 124.3, 124.0, 70.1, 61.2, 51.2; FT-IR (NaCl, DCM
solution) v/cm-1 3260, 3061, 2967, 2850, 2355, 1581, 1562, 1494, 1453, 1419, 1265,
1207, 1128, 1073, 845, 802, 780, 746, 701.

HO

— N

tr««s-5,6-Dihydro-6-(2-bromo-anilylamino)-l,10-phenanthroline-5-ol,
adduct)

HN

N—

(2-Br-anilyl

Purification by crystallization from CHCf/Hexanes yielded a solid (m.p. 130°C)
in 83% yield. 'H NMR (400 MHz, CDCI3 ) 5 8.10 (1H, d, J = 7.69 Hz), 7.71 (1H, d, J =
8.06 Hz), 7.48 (2H, d, J = 8.06 Hz), 7.47 (2H, d, J = 7.69 Hz), 7.38 (1H, dd, J = 4.76,
7.69 Hz), 7.28 (1H, dd, J = 4.76, 7.69 Hz), 7.13 (1H, t, J = 8.42, 7.32 Hz), 6.73 (1H, d, J
= 7.69 Hz), 6.66 (1H, t, J = 7.32, 7.69 Hz), 5.13 (1H, d, J = 10.62 Hz), 4.91 (1H, t, J =
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7.69, 10.25 Hz), 4.78 (1H, d, J = 8.42 Hz); 13C NMR (100 MHz, CDC13)

8

150.4, 149.9,

149.8, 149.2, 144.2, 134.9, 134.5, 134.4, 133.0, 132.8, 128.9, 124.6, 124.5, 119.7, 112.7,
110.7, 70.6, 59.0; FT-IR (NaCl, DCM solution) v/cm-1 3197, 3064, 2957, 2924, 2853,
1593, 1560, 1507, 1458, 1420, 1321, 1283, 1126, 1076, 1034, 1019, 798, 744, 664.

HO

HN

—N
f/7wis-5,6-Dihydro-6-(2-chloro-anilylamino)-l,10-phenanthroline-5-ol,
adduct)

N—

(2-Cl-anilyl

Purification by crystallization from CHC^/Hexanes yielded a solid (m.p. 155°C)
in

8 6

% yield. 'H NMR (400 MHz, CDCI3 ) 5

8 .6 6

(2H, t, J = 4.76, 4.39 Hz), 8.05 (1H, d,

J = 7.69 Hz), 7.72 (1H, d, J = 7.69 Hz), 7.41 (1H, dd, J = 4.76, 8.06 Hz), 7.33 (1H, dd, J =
4.76, 8.06 Hz), 7.24 (1H, d, J = 7.69 Hz), 7.04 (1H, t, J = 6.96, 7.32 Hz),

6 .6 8

(1H, d, J =

8.06 Hz), 6.62 (1H, t, J = 7.32, 8.06 Hz), 5.21 (1H, d, J = 6.59 Hz), 5.03 (1H, d, J = 10.62
Hz), 4.78 (1H, t, J = 6.59, 10.25 Hz); 13C NMR (100 MHz, CDC13) 8 150.4, 149.5, 149.3,
149.2, 144.1, 136.5, 135.9, 135.2, 134.0, 129.5, 128.2, 124.7, 124.6, 119.4, 118.1, 112.5,
69.4, 58.4; FT-IR (NaCl, DCM solution) v/cm-1 3175, 3065, 2956, 2917, 2849, 1596,
1560, 1507, 1458, 1419, 1323, 1123, 1075, 1033, 797, 742, 6 6 8 .

113

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

tmts-5,6-Dihydro-6-(2-cyano-anilylamino)-l,10-phenanthroline-5-oI,
adduct)

(2-CN-aniIyl

Purification by crystallization from CHCU/Hexanes yielded a solid (m.p. 149°C)
in 73% yield. .

NMR (400 MHz, CDC13) 5 8.65 (2H, t, J = 3.66, 4.39 Hz), 8.13 (1H, d,

J = 7.69 Hz), 7.70 (1H, d, J = 7.69 Hz), 7.34-7.34 (m, 3H), 7.28 (1H, dd, J = 4.76, 7.69
Hz), 6.75 (1H, d, J = 6.59 Hz), 6.72 (1H, t, J = 4.76, 7.69 Hz), 5.55 (1H, d, J = 7.69 Hz),
5.37 (1H, d, J = 10.25 Hz), 4.98 (1H, t, J = 8.97, 8.97 Hz); 13C NMR (100 MHz, CDCI3 )
5 150.9, 150.1, 150.0, 149.8, 149.6, 135.0, 134.8, 134.7, 134.6, 133.4, 132.2, 124.7,
124.4, 117.8, 117.6, 111.6, 96.4, 70.0, 58.6; FT-IR (NaCl, DCM solution) v/cm-1 3243,
2213, 1604, 1578, 1520, 1420, 1327, 1077, 1042, 798, 746,

6 6 8

.

HO

~N

fra«,s-5,6-Dihydro-6-(2-ethyI-aniIylamino)-l,10-phenanthroline-5-ol,
adduct)

HN

N—

(2-Et-aniIyl

Purification by crystallization from CHC13/Hexanes yielded a solid (m.p. 146°C)
in 97% yield. lU NMR (400 MHz, CDC13) 5

8 .6 6

(1H, d, J = 4.76 Hz), 8.63 (1H, d, J =

4.76 Hz), 8.06 (1H, d, J = 7.69 Hz), 7.70 (1H, d, J = 7.69 Hz), 7.32 (2H, dd, J = 4.76,
7.69), 7.23 (2H, dd, J = 4.76, 7.69 Hz), 7.09 (1H, d, J = 7.32 Hz), 7.03 (1H, t, J = 7.69,
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7.69 Hz), 6.75 (1H, t, J = 7.32, 7.32 Hz), 6.57 (1H, d, J = 8.06Hz), 5.17 (1H, d, J = 10.62
Hz), 4.85 (1H, d, J = 10.62 Hz), 2.5 (2H, q, J = 7.32, 7.69 Hz), 1.17 3H, (t, J = 7.69, 7.32
Hz); 13C NMR (100 MHz, CDC13) 5 150.3, 149.8, 149.78, 149.4, 144.5, 135.5, 134.8,
134.5, 133.5, 128.6, 128.5, 127.3, 124.5, 124.4, 118.8, 111.1, 70.3, 58.4, 24.1, 13.2; FTIR (NaCl, DCM solution) v/cm-1 3339, 3190, 3063, 2964, 2930, 2872, 1603, 1585, 1563,
1515, 1453, 1419, 1307, 1265, 1126, 1076, 1042, 909, 882, 799, 747.

HO

■=N

HN

N—

tra«i-5,6-Dihydro-6-(4-ethyl-anilylamino)-l,10-phenanthroline-5-ol,
adduct)

(4-Et-anilyl

Purification by crystallization from CHCf/Hexanes yielded a solid (m.p. 208°C)
in 78%. ‘H NMR (400 MHz, CDC13) 5 8.72 (1H, d, J = 4.76 Hz), 8.69 (1H, d, J = 3.30
Hz), 8.06 (1H, d, J = 7.69 Hz), 7.79 (1H, d, J = 7.69 Hz), 7.35 (2H, dd, J = 5.13, 4.76
Hz), 7.25 (2H, dd), 7.01 (2H, d, J = 8.42 Hz), 6.66 (2H, d, J = 8.42 Hz), 5.05 (1H, d, J =
10.62 Hz), 4.79 (1H, d, J = 10.62 Hz), 2.55 (2H, q, J = 7.69, 7.69 Hz), 1.18 (3H, t, J =
7.69, 7.69 Hz); 13C NMR (100 MHz, CDC13) 5 150.0, 149.5, 149.0, 145.1, 135.6, 134.9,
134.8, 134.7, 134.0, 129.0, 124.6, 124.5, 113.8, 70.2, 58.9, 28.0, 16.0; FT-IR (NaCl,
DCM solution) v/cm-1 3285, 3055, 2962, 2928, 2869, 1616, 1582, 1563, 1519, 1420,
1322, 1266, 1184, 1125, 1077, 1041, 823, 799, 746, 735
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ftYms-5,6-Dihydro-6-azido-l,10-phenanthroIine-5-ol, (azido alcohol)
Purification by column chromatography (SiC>2 , CHCl3/ 5 % MeOH) yielded a solid
(m.p. 83°C) in 87% yield. *H NMR (400 MHz, CDC13)

8

8.71 (2H, dd, J = 4.76, 4.76

Hz), 8.06 (1H, d, J = 7.32 Hz), 7.91 (1H, d, J = 7.69 Hz), 7.37 (2H, dd, J = 4.76, 7.69
Hz), 5.06 (1H, d, J = 10.25 Hz), 4.87 (1H, d, J = 9.89 Hz); 13C NMR (100 MHz, CDC13)
5 150.16, 149.74, 149.68, 149.05, 135.35, 134.93, 134.28, 130.05, 124.72, 124.49, 71.77,
64.97; FT-IR (NaCl, DCM solution) v/cm-1 3205, 3064, 2925, 2855, 2239, 2108, 1582,
1564,1420,1298, 1264, 1074, 800, 744.

tra«s-5,6-Dihydro-6-(pyridin-2-yIamino)-l,10-phenanthrolin-5-ol (FSL)
Purification by column chromatography (SiC>2 , CHCl3/ 5 %

MeOH)

and

recrystalization in CHCI3 yielded a white solid (m.p. 220°C) in 47%. *H NMR (400 MHz,
MeOD)

8

8.67 (2H, dd, J = 4.76, 4.76 Hz), 8.04 (1H, d, J = 7.69 Hz), 7.96 (1H, d, J =

5.13 Hz), 7.84 (1H, d, J = 7.69 Hz), 7.38-7.48 (3H, m), 6.62 (2H, d overlap dd, J = 8.42,
6.22 Hz), 5.39 (1H, d, J = 8.79 Hz), 5.02 (1H, d, J = 8.79 Hz); 13C NMR (100 MHz,
CDCI3 )

8

159.0, 151.1, 150.2, 149.8, 149.7, 134.5, 134.3, 134.2, 133.5, 131.8, 129.4,

116

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

124.3, 124.0, 114.2, 70.4, 61.1, 55.4, 50.9; FT-IR (NaCl, DCM solution) v(cm-l) 3270,
3063, 2835, 2208, 1611, 1583, 1564, 1512, 1418, 1247, 1178, 1035, 802, 747, 730;

OM e

HO

HN

—N
H3C

ch

3

6-(4-Methoxybenzylamino)-5,6-dihydro-2,9-dimethyl-l,10-phenanthrolin-5-ol, (2,9diMe-(4-MeO-benzyl) adduct)

Purification by column chromatography (SiC>2 , CHCl3/3% MeOH) yielded a solid
(m.p. 80 °C) in 33%. *H NMR (400 MHz, CDC13) 5 7.75 (1H, d, J = 7.69 Hz), 7.62 (1H,
d, J = 7.69 Hz), 7.23 (2H, d, J = 8.42 Hz), 7.13 (2H, dd, J = 7.69; 7.69 Hz), 6.84 (2H, d, J
= 8.42 Hz), 4.73 (1H, d, J = 8.42 Hz), 3.91 (1H, d, J = 8.06 Hz), 3.89 (1H, d, J = 12.81
Hz), 3.76 (4H, d, J = 11.35 Hz), 2.65 (2H, d, J = 2.2 Hz); 13C NMR (100 MHz, CDC13) 5
159.2, 159.0, 158.8, 150.3, 149,1, 135.3, 135.2, 131.7, 131.3, 130.3, 129.4, 124.0, 123.6,
114.1, 70.5, 61.1, 55.4, 50.8, 24.9, 24.8; FT-IR (NaCl, DCM solution) v/cm'1 3310.5,
3060.7, 2956.3, 2917.5, 2848.7, 1611.2, 1582.9, 1571.0, 1540.8, 1512.0, 1448.3, 1372.5,
1300.8, 1247.0, 1176.4, 1034.5, 831.2, 734.2.
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G en era l m e th o d f o r reso lu tio n o f ra ce m ic a n d d ia stereo m eric a m in o a lco h o l-1 ,1 0 p h e n a n th r o lin e derivatives

To a solution of aminoalcohol (1.0 equiv) in absolute methanol was added Smandelic acid (1.0-1.2 equiv). The mixture was heated to reflux while stirring and after 1
hour allowed to cool to room temperature. After one day white precipitate or crystals of
the diastereomeric salt formed which were filtered and washed with cold methanol.
Repeated heating and cooling steps with the remaining solution gave more diastereomeric
salts, which were separately basicified with aqueous NaOH solution (IN) to pH 8.0-9.0
and then extracted with CHCI3. Combined CHCI3 layer was dried over MgS0 4 , filtered,
concentrated of solvent to afford enantiopure aminoalcohol products.
OM e

HO

HN

(+)- and (-)-fnwis'-6-(4-Methoxy-benzylamino)-5,6-dihydro-l,10-phenanthroIine-5-ol,
((+) and (-)-4-MeO-benzyl adduct)

Purification by column chromatography (SiC>2 , CHCl3/5% MeOH) yielded a solid (m.p.
190°C) in 62-74%. *H NMR (400 MHz, CDC13) 5 8.65 (2H, d, J = 4.76 Hz), 7.91 (1H, d,
J = 6.96 Hz), 7.79 (1H, d, J = 7.69 Hz), 7.26-7.30 (2H, m), 7.24 (2H, d, J = 8.42 Hz), 6.48
(2H, d, J = 8.79 Hz), 4.83 (1H, d, J = 9.52 Hz), 4.00 (1H, d, J = 9.52 Hz), 3.94 (1H, d, J =
12.81 Hz), 3.79 (1H, d, J = 12.45 Hz), 3.77 (3H, s); 13C NMR (100 MHz, CDC13) 5
159.0, 151.1, 150.2, 149.8, 149.7, 134.5, 134.3, 134.2, 133.5, 131.8, 129.4, 124.3, 124.0,
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114.2, 70.4, 61.1, 55.4, 50.9; FT-IR (NaCl, DCM solution) v(cm-l) 3270, 3063, 2835,
2208, 1611, 1583, 1564, 1512, 1418, 1247, 1178, 1035, 802, 747, 730; Anal Calcd for
C20H19N3O2: C, 72.05; H, 5.74; N, 12.60. Found: C, 71.66; H, 6.14; N, 12.75. After
resolution (+)-4-MeO-benzyl adduct [a]D = +12.1° (c =0.038g/mL MeOH); (-)-4-MeObenzyl adduct [a]o = -13.4° (c =0.04g/mL MeOH).
X-ray analysis: X-ray quality crystals were grown from a chloroform/hexanes mixture.
A colorless sample approximately 0.25 x 0.25 x 0.1 mm was chosen by size, habit, and
polarized light microscopy. The compound crystallized in the monoclinic system in the
space group P2i/c (#14)' a=10.4198(0.0018)A, b=14.6148(0.0023) A , c=l 1.5805(0.0021)

A,

p=109.8220(0.0146)°,

V=1659.01

A 3,

data

collected

(total/unique/lo>4alo)=3414/2858/1821, scan method co/20, Z=4, dcaic= 1.33 g/cc, p=0.09
mm'1, T=295K, Z=0.7107A, Fooo= 696e, structural parameters = 227, Ri=0.0729,
wRi=0.2321 (w=([E (F02) + (0.1318P)2 + 1.34P])"1 where P=(Max( Fo2,0)+2Fc2)/3).
Nonius CAD4, 2 0 max= 49.880.

The structure was solved by direct methods using

SHELXS and refined on F2 in full matrix least squares using SHELXL. All non-hydrogen
atoms were refined anisotropically. Hydrogens were placed in a combination of observed
and calculated positions. The data were corrected for absorption by an empirical psi-scan
determination. The largest unassigned peak in the final difference map was 0.5e/A3
located near N3. CCDC 221492 X-ray data may be obtained free of charge from the
Cambridge Crystallographic Data Centre, 12 Union Rd, Cambridge CB21EZ, UK, or
ccdc.cam.ac.uk
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CH3
Ph

—N

N—

^«ns-(5i?,6i?)-6-((if)-l-PhenyIethylamino-5,6-dihydro-l,10-phenanthroline-5-ol,
((R ,R )-a -(+ ) adduct)
*HNMR (400MHz, CDCI3 )

8

8.62 (2H, dd, J = 3.30; 4.76 Hz), 7.91 (1H, d, J = 7.69 Hz),

7.62 (1H, d, J = 7.69 Hz), 7.34-7.17 (7H, m), 4.76 (1H, d, J = 9.15 Hz), 4.06 (1H, q, J =
6.59 Hz), 3.94 (1H, d, J =9.15 Hz), 1.33 (3H, d, J = 6.59 Hz); 13CNMR (100MHz,
CDCI3 ) 5 150.74, 149.84, 149.77, 149.44, 145.43, 1134.85, 1134.79, 134.52, 134.36,
128.88, 127.59, 126.98, 126.63, 124.25, 124.06, 70.83, 59.68, 56.65, 24.45; FT-IR (NaCl,
DCM solution) v/cm' 1 3281, 3060, 3029, 2967, 2923, 2867, 1653, 1581, 1560, 1541,
1456, 1428, 1418, 1127, 1074, 1039, 801, 747, 702; (m.p. 72°C); [a]D = -5.28° (c
=0.05g/mL MeOH).

ch

3

Ph

N—

trans-(5iS',65)-6-((i?)-l-Phenylethylamino-5,6-dihydro-l,10-phenanthroline-5-ol,
((5 , 5 ) - a - ( + ) adduct)
‘HNMR (400MHz, CDC13) 8 8.73 (2H, dd, J = 4.03; 3.36 Hz), 7.82 (1H, d, J = 7.32 Hz),
7.66 (1H, d, J = 7.32 Hz), 7.36-7.26 (7H, m), 4.68 (1H, d, J = 5.86 Hz), 3.97 (1H, q, J =
6.22, 5.86 Hz), 3.73 (1H, d, J = 7.69 Hz), 1.38 (3H, d, J = 6.22 Hz); 13CNMR (100MHz,
CDCI3 )

8

150.71, 150.22, 149.78, 149.66, 144.80, 135.53, 134.92, 134.06, 133.95,

128.91, 127.61, 126.99, 124.26, 123.75, 71.25, 58.91, 56.66, 25.16; FT-IR (NaCl, DCM
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solution) v/cm ' 1 3289, 3060, 2963, 2924, 2859, 1652, 1582, 1561, 1491, 1456,
1428,1372, 1267, 1217, 1126, 1073, 1044, 1026, 800, 756, 702; (m.p. 75°C); [oc]D =
+29.82° (c = 0.05g/mL MeOH).

G en era l m e th o d f o r th e p re p a ra tio n o f 5 ,6 -o x a zo lid in o n e -l,1 0 -p h e n a n th ro lin e
derivatives

Amino alcohol (1.0 eq.) was added to a solution (2.5-3.0 eq.) of Li'OBu in DCM
under argon. The mixture was stirred at room temperature for 20 min and placed in an ice
bath. Triphosgene (1.0 eq.), pre-dissolved in DCM, was added dropwise to the solution,
stirred 2 hrs at 0°C and then allowed to warm to room temperature. After the reaction was
completed after ca. 16 hrs (monitored by TLC, alumina, CHCl3/ 5 % MeOH), it was
quenched with water. The layers were separated; the aqueous layer adjusted to pH 9.010.0 and extracted with CHCI3 . The combined organic layers were washed with water
and brine, dried over anhydrous Na2 S0 4 , and filtered. Evaporation of the solvent gave the
crude product.

CH;
Ph

N—

(3aS,llbA)-3,3a-Dihydro-3-((7f)-l-phenylethyl)oxazolo[5,4-f|[l,10]phenanthrolin2(llbH)-one, ((S ,S )-o xa -a -(+ ) adduct)

Purification by column chromatography (Si0 2 , CHCb/3% MeOH) yielded a solid
(m.p. 208 °C) in 91%. 'HNMR (400MHz, CDC13)

8

8.83 (1H, d, J = 4.39 Hz), 8.70 (1H,

121

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

app t, J = 3.66, 2.56 Hz), 7.88 (1H, d, J = 7.69 Hz), 7.48 (2H, d, = 7.32 Hz), 7.33-7.42
(4H, m), 7.06 (2H, d, J = 4.03 Hz), 5.42 (1H, q, J = 7.32, 7.32 Hz), 5.26 (1H, d, J = 13.91
Hz), 4.77 (1H, d, J = 13.91 Hz), 1.80 (3H, d, J = 7.32 Hz); 13CNMR (100MHz, CDC13)

6

160.1, 150.6, 150.5, 149.7, 149.5, 141.0, 131.7, 131.0, 130.9, 130.0, 129.0, 128.2, 127.0,
124.3, 123.6, 75.8, 61.1, 54.2, 15.9; FT-IR (NaCl, DCM solution) v/cm' 1 3058, 2980,
2941, 1762, 1653, 1557, 1541, 1421, 1363, 1282, 1179, 1122, 1032, 798, 748, 702, 648;
[oc]D = +11°; Anal Calcd for C2 1 H 17 N 3 O2 : C, 73.45; H, 4.99; N, 12.24. Found: C, 73.36;
H, 4.83; N, 12.33.

(3a7?,llb/f)-3,3a-Dihydro-3-((/?)-l-phenylethyl)oxazolo[5,4-f][l,10]phenanthrolin2(llbH)-one, ((2?,R)-oxa-a-(+) adduct)

Purification by column chromatography (SiC>2 , CHCl3 / 3 % MeOH) yielded a solid
(m.p. 229 °C) in 79%. !HNMR (400MHz, CDC13) 5 8.84 (1H, d, J = 4.76 Hz), 8.78 (1H,
d, J = 4.76 Hz), 7.90 (1H, d, J = 7.69 Hz), 7.75 (2H, d, = 8.06 Hz), 7.53 (2H, d, J = 7.69
Hz), 7.37-7.45 (3H, m), 7.28-7.32 (2H, m), 5.26 (1H, d, J = 13.91 Hz), 5.06 (1H, q, J =
6.96, 6.96 Hz), 4.75 (1H, d, J = 13.91 Hz), 1.87 (3H, d, J = 6.96 Hz); 13CNMR (100MHz,
CDCI3 ) 5 159.2, 150.6, 150.5, 149.9, 149.4, 139.5, 131.2, 131.1, 130.5, 130.0, 129.0,
128.0, 127.0, 124.4, 123.7, 75.9, 62.0, 60.0, 17.8; FT-IR (NaCl, DCM solution) v/cm' 1
3058, 2976, 2936, 1769, 1554, 1422, 1371, 1278, 1173, 1149, 1018, 955, 800, 776, 748,
696; [oc]D = +1.16° (c = 0.037/mL CHC13).
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(+) and (-)-3-(4-Methoxybenzyl)-3,3a-dihydrooxazolo[5,4-f| [l,10]phenanthrolin-2
(llbH)-one, ((+) and (-)-oxa-4-MeO adduct)
Purification by column chromatography (SiC>2 , CHCl3/5% MeOH) yielded a solid
(m.p. 199°C) in 78% yield. *H NMR (400 MHz, CDC13) 8 8.81 (2H, m), 7.86 (2H, m),
7.40-7.36 (2H, m), 7.23 (2H, d, J = 8.2 Hz), 5.24 (1H, d, J = 13.9 Hz), 5.06 (1H, d, J =
15.2 Hz), 4.60 (1H, d, J = 15.2 Hz), 4.41 (1H, d, J = 13.9 Hz), 3.73(3H, s); 13C NMR
(100 MHz, CDCI3 ) 5 160.4, 159.8, 150.5, 150.0, 149.4, 131.1, 131.0, 130.5, 130.0, 129.9,
126.4, 124.3, 123.8, 114.5, 75.9, 60.0, 55.3, 49.3; FT-IR (NaCl, DCM solution) v/cm'1
3063, 3002, 2956, 2838, 1769, 1611, 1557, 1514, 1419, 1248, 1175, 1027, 800. Anal
Calcd for 3 C2 1 H 17N 3 O3 CHC13 H20 : C, 63.24; H, 4.48; N, 10.37. Found: C, 63.14; H,
4.81; N, 10.36; (+)-oxa-4-MeO [<x]D = +2.35° (c = 0.023g/mL MeOH), (-)-oxa-4-MeO
[<x]D = -13.6° (c = 0.029g/mL M eOH).
X-ray analysis: X-ray quality crystals were grown from chlorofom/hexanes mixture. A
colorless sample approximately 0.3 x 0.3 x 0.3 mm was cut from multilayered plates and
chosen by size, habit, and polarized light microscopy. The compound crystallized in the
monoclinic system in the space group P2i/n (non-standard setting of P2i/c #14),
a=15.7246(0.0092)A, b=5.5890(0.0012) A , c=28.745(0.0075) A , 0=120.5951(0.0371)°,
V=2174.61 A 3 , data collected (total/unique/Io>4aIo)=4779/3716/1781, scan method
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co/20, Z=4, dcaic=1.10 g/cc, |i=0.45 mm' 1 T=295K, X=0.7107A, F0oo=984e, structural
parameters=283, Rl=0.0947, wRl=0.3083 (Weight = ([E (F02) + (0.1458P)2 + 4.63P])1
where P=(Max( Fo2 ,0)+2Fc2 )/3). Nonius CAD4, 20max=49.83°. The structure was solved
by direct methods using SIR, and refined in full matrix least squares using SHELXL. All
non-hydrogen atoms were refined anisotropically.

Hydrogens were placed in a

combination of observed and calculated positions.

There was one molecule of

chloroform in each asymmetric unit.

Application of absorption corrections did not

improve the model. There was some disorder of the chloroform. Adjusting for variable
site occupancy for the chlorine atoms resulted in unit occupancy within experimental
error. No attempt beyond adjusting the site occupancy for the chlorine atoms was applied
to account for this disorder. The largest unassigned peak in the final difference map was
0.51 e/A3 located near Cll. CCDC 221493 X-ray data may be obtained free of charge
from the Cambridge Crystallographic Data Centre, 12 Union Rd, Cambridge CB21EZ,
UK, or ccdc.cam.ac.uk

—N

N—

(3aR,llbR)-3-Benzyl-3,3a-dihydrooxazolo[5,4-f][l,10]phenanthrolin-2(llbH)-one,
(oxa-benzyl adduct)
Purification by column chromatography (SiC>2 , CHCl3 / 5 % MeOH) yields a solid
(m.p. 169°C) in 74% yield. !H NMR

8

8.80 (2H, d, J = 4.76 Hz), 7.86 (1H, d, J = 7.69

Hz), 7.80 (1H, d, J = 7.69 Hz), 7.39 (1H, dd, J = 4.76, 4.76 Hz), 7.29-7.35 (6 H, m), 5.26
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(1H, d, J = 13.91 Hz), 5.05 (1H, d, J = 15.38 Hz), 4.70 (1H, d, J =15.38 Hz), 4.46 (1H, d,
J = 13.91 Hz); 13C NMR 5 160.4, 150.5, 150.4, 150.0, 149.2, 134.6, 131.0, 130.7, 130.6,
130.2, 129.2, 128.6, 128.4, 124.4, 123.9, 75.9, 60.5, 49.9; FT-IR (NaCl, DCM solution)
v/cm' 1 3061, 3004, 2971, 1766, 1554, 1420, 1368, 1285, 1176, 1149, 1054, 1025, 800,
747; (m.p. 169°C).

—N

N=

3-(4-Ethylphenyl)-3,3a-dihydrooxazoIo[5,4-f|[l,10]phenanthrolin-2(llbH)-one,
(oxa-4-Et-anilyl adduct)
Purification by column chromatography (Si0 2 , CHCl3 / 5 % MeOH) yielded a solid
(m.p. 227°C) in 73%. lU NMR (400 MHz, DMSO)

8

8.79 (1H, d, J = 4.76 Hz), 8.7 (1H,

d, J = 4.03 Hz), 7.97 (1H, d, J = 7.69 Hz), 7.59 (1H, dd, J = 4.76, 4.76 Hz), 7.36 (6 H, m),
7.15 (1H, d, J = 8.06 Hz), 5.78 (1H, d, J = 13.55 Hz), 5.66 (1H, d, J = 13.91 Hz), 2,66
(2H, q, J = 7.69, 7.69 Hz), 1.23 (3H, t, J = 7.69, 7.69 Hz);
8

13

C NMR (100 MHz, DMSO)

157.9, 150.9, 150.2, 149.8, 149.5, 142.5, 136.2, 131.5, 131.2, 130.9, 130.1, 129.1,

124.9, 124.3, 123.5, 76.0, 60.0, 28.2, 16.3; FT-IR (KBr) v/cm' 1 3055, 2963, 1770, 1600,
1554, 1518, 1424, 1376, 1340, 1272, 1201, 1167, 1137, 1110, 1077, 1022, 967, 887, 850,
826, 797, 747, 679, 628.
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H3a ,

—N

r

.P h

N—

(la>S',9b/?)-la,9b-Dihydro-l-((/?)-l-phenylethyl)-lH-azirino[2,3-f][l,10]phenanthroline, (a(+)-aziridine)
In a two-necked flask, fitted with an addition funnel, condenser and a magnetic
stirrer, was added under argon atmosphere the diastereoisomeric mixture of (5R,6R,VR)
and/or (5S,6S,VR) aminoalcohol derivative (1.59 g, 5 mmol), dry Et3N (1.05 mL) and
dry DCM (15 mL). The mixture was cooled to 0°C and to it was added dropwise a
solution of methanesulfonyl chloride (0.63 g, 5.5 mmol) in dry DCM (5 mL). The
reaction was stirred at 0°C until no more starting material (by TLC alumina, CHCI3/ 5%
MeOH), the in situ mesylated compounds were allowed to warm to room temperature and
stirred further for 12 hrs. The reaction mixture was then quenched with water. The layers
were separated and the aqueous layer was extracted several times with DCM (3 x 1 0 mL).
The combined organic layer was washed with water, brine, and dried over anhydrous
Na2 S0 4 , filtered and concentrated in vacuo. The crude product was purified by column
chromatography (Si0 2 , CHCl3 / 5 % MeOH) to give (laS,9bR)-la,9b-dihydro-l-((R)-lphenylethyl)-lH-azirino [2,3-f][l,10]phenanthroline (1.19 g, 80%) as a thick yellow
liquid. *H NMR (400 MHz, CDC13) 5 8.81 (1H, d, J = 4.76 Hz), 8.77 (1H, d, J = 4.76
Hz), 7.90 (1H, d, J = 7.69 Hz), 7.46 (1H, d, J = 7.69 Hz), 7.34 (1H, dd, J = 4.76, 7.69
Hz), 7.25-7.30 (5H, m), 7.20 (1H, dd, J = 4.76, 7.69 Hz), 3.30 (1H, d, J = 5.86 Hz), 3.09
(1H, d, J = 6.22 Hz), 2.97 (1H, q, J = 6.59, 6.59 Hz), 1.51 (3H, d, J = 6.59 Hz); 13C NMR
(100 MHz, CDCI3 ) 8 149.8, 149.6, 149.4, 143.7, 139.3, 137.0, 131.0, 130.9, 128.5, 128.0,

126

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

127.3, 126.7, 123.7, 123.6, 69.6, 44.2, 42.7, 23.2; FT-IR (NaCl-DCM solution) v/cm' 1
3393, 3058, 2970, 2926, 1560, 1494, 1427, 1131, 1096, 1071, 1039, 934, 792, 746, 704;
[<x]D = - 6.4°
and (57?,67?)-5,6-Dihydro-7V5,/V6-bis((7?)-l-phenylethyl)-l,10-phenanthroline 5,6-diamine

(5S,6S)~

In a dry two-neck flask, fitted with an addition funnel, condenser and magnetic
stirrer,

was

placed

with

stirring

under

argon

atmosphere

5,6-aziridine-l,10-

phenanthroline (1.03 g, 3.45mmol) and anhydrous Mg(C 1 0 4 ) 2 (1.00 g, 4.48 mmol) in
freshly dried acetonitrile (minimum amount) until complete dissolution of salt. The
reaction mixture was cooled to 0°C and (i?)-a-phenylethylamine (0.542g, 4.48 mmol)
added. The resulting solution was then heated to reflux until the reaction was complete,
which took ca. 2 days. A viscous residue formed. The reaction was quenched with water
and washed with hexanes to get rid excess amine. The layers were separated and the
aqueous layer was extracted with CHCI3 (3 x 25 mL). The combined organic layers were
washed with water and brine and dried over anhydrous Na2 S0 4 , filtered and concentrated
in vacuo to give crude mixture of the 5,6-diamines. The mixture of 5,6-diamines was
purified and separated by column chromatography (SiC>2 , CHCb/3% MeOH) to give
enantiopure material in 79% yield.

Me

Me

—N

N—

(5/?,6i?)-5,6-Dihydro-iV5,M>-bis((2?)-l-phenylethyl)-l,10-phenanthroline-5,6-diamine
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Recrystalization in CHCI3 yielded a yellow solid (m.p. 108°C).’H NMR (400 MHz,
CHCI3 ) 5 8.726 (2H, dd, J = 1.46, 3.30 Hz), 7.428 (2H, dd, J = 1.46, 6.22 Hz), 7.2027.347 (12H, m), 3.955 (2H, s), 3.737 (2H, q, J = 6.59, 6.59 Hz), 1.160 (3H, d, J = 6.59
Hz); 13C NMR (100 MHz, CDC13) 5 150.4, 150.1, 145.4, 138.0, 133.8, 129.3, 127.3,
126.8, 124.1, 56.1, 55.5, 24.5; FT-IR (NaCl-DCM solution) v/cm' 1 3338, 3269, 3063,
3028, 2966, 2927, 2864, 2208, 1562, 1492, 1451, 1425, 1370, 1125, 909, 754, 730, 702;
[oc]D = -138° (c =0.043g/mL MeOH).

X-ray analysis: C2 (RRRR) diamine ligand
Table 1. Crystal data and structure refinement for vjc476fm (C2 RRRR).
Identification code

vjc476fm

Empirical formula

C29 H29 C13 N4

Formula weight

539.91

Temperature

100(2) K

Wavelength

0.71073 ~

Crystal system

Tetragonal

Space group

14(1)

Unit cell dimensions

a = 11.8038(3)«

= 90oo.

b = 11.8038(3) ~

= 90oo.

c = 19.8714(8) ~

= 90oo
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Volume

2768.68(15) = 3

Z

4

Density (calculated)

1.295 Mg/m3

Absorption coefficient

0.356 mm"'

F(000)

1128

Crystal size

0.39 x 0.25 x 0.10 mm 3

Theta range for data collection

2.01 to 27.47oo.

Index ranges

-15<=h<= 15, -15<=k<=15, -25<=1<=25

Reflections collected

11723

Independent reflections

2721 [R(int) = 0.0303]

Completeness to theta = 27.47oo

85.9 %

Absorption correction

sadabs

Max. and min. transmission

0.9653 and 0.8733

Refinement method

Full-matrix least-squares on F^

Data / restraints / parameters

2721 / 163/225

Goodness-of-fit on

0.932

Final R indices [I>2sigma(I)]

R1 = 0.0378, wR2 = 0.0923

R indices (all data)

R1 = 0.0427, wR2 = 0.0946

Absolute structure parameter

-0 .01(6)

Largest diff. peak and hole

0.252 and -0.127 e . ~ " 3
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Table 2. Bond lengths [~] and angles [oo] for vjc476fm.

C1(1)-C(1S)

1.750(4)

C1(2)-C(1S)

1.698(4)

C1(2)-C(1S)#1

1.761(4)

C(1S)-C(1S)#1

1.165(8)

C(1S)-C1(2)#1

1.761(4)

N(l)-C(5)

1.347(2)

N (l)-C(l)

1.348(3)

C(l)-C(2)

1.381(4)

N(2)-C(6)

1.470(2)

N(2)-C(7)

1.472(2)

C(2)-C(3)

1.379(3)

C(3)-C(4)

1.394(3)

C(4)-C(5)

1.395(3)

C(4)-C(6)

1.510(3)

C(5)-C(5)#2

1.473(4)

C(6)-C(6)#2

1.551(3)

C(7)-C(9)

1.500(3)

C(7)-C(8)

1.526(3)

C(7)-C(9A)

1.529(4)

C(9)-C(14)

1.343(12)

C(9)-C(10)

1.369(3)
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C(10)-C(ll)

1.365(11)

C(ll)-C(12)

1.38(2)

C(12)-C(13)

1.28(2)

C(13)-C(14)

1.455(17)

C(9A)-C(10A)

1.362(7)

C(9A)-C(14A)

1.399(7)

C(10A)-C(11A)

1.372(9)

C(11A)-C(12A)

1.374(9)

C(12A)-C(13A)

1.373(9)

C(13A)-C(14A)

1.400(5)

C(1 S)-C1(2)-C(1 S)#l

39.3(3)

C(1 S)# 1-C( 1S)-C1(2)

73.3(4)

C(1S)#1-C(1S)-C1(1)

173.8(4)

C1(2)-C(1S)-C1(1)

107.7(2)

C(1S)#1-C(1S)-C1(2)#1

67.4(3)

Cl(2)-C( 1S)-C1(2)# 1

113.7(2)

Cl( 1)-C( 1S)-C1(2)# 1

107.0(2)

C(5)-N(l)-C(l)

116.4(2)

N(l)-C(l)-C(2)

124.3(2)

C(6)-N(2)-C(7)

116.93(15)

C(3)-C(2)-C(l)

118.28(19)

C(2)-C(3)-C(4)

119.3(2)
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C(5)-C(4)-C(3)

118.05(19)

C(5)-C(4)-C(6)

119.83(15)

C(3)-C(4)-C(6)

121.99(18)

N(l)-C(5)-C(4)

123.51(17)

N(l)-C(5)-C(5)#2

117.05(12)

C(4)-C(5)-C(5)#2

119.44(10)

N(2)-C(6)-C(4)

107.39(14)

N(2)-C(6)-C(6)#2

114.62(19)

C(4)-C(6)-C(6)#2

110.55(12)

N(2)-C(7)-C(9)

116.4(3)

N(2)-C(7)-C(8)

108.13(16)

C(9)-C(7)-C(8)

111.42(17)

N(2)-C(7)-C(9A)

108.7(2)

C(9)-C(7)-C(9A)

9.9(5)

C(8)-C(7)-C(9A)

110.10(18)

C(14)-C(9)-C(10)

117.1(6)

C(14)-C(9)-C(7)

123.3(6)

C(10)-C(9)-C(7)

119.0(2)

C(ll)-C(10)-C(9)

123.7(7)

C(10)-C(ll)-C(12)

115.5(10)

C(13)-C(12)-C(ll)

124.9(13)

C(12)-C(13)-C(14)

117.7(13)

C(9)-C(14)-C(13)

120.3(10)
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C( 10A)-C(9A)-C( 14A)

115.7(4)

C( 10A)-C(9A)-C(7)

121.7(4)

C(14A)-C(9A)-C(7)

122.3(4)

C(9A)-C(10A)-C(11A)

125.0(5)

C(10A)-C(11A)-C(12A) 118.9(5)
C(13A)-C(12A)-C(11A) 118.6(5)
C(12A)-C(13A)-C(14A) 121.4(5)
C(9A)-C(14A)-C( 13A)

120.3(4)

Symmetry transformations used to generate equivalent atoms:
#1

-x+2 ,-y+0 ,z+ 0

# 2

-x+2 ,-y+l,z + 0
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Table 3. Torsion angles [oo] for vjc476fin.

C( 1S)# 1-Cl(2)-C( 1S)-C1( 1)

-173.6(3)

C( 1S)# 1-C1(2)-C(1S)-C1(2)# 1

-55.2(3)

C(5)-N(l)-C(l)-C(2)

-2.1(3)

N(l)-C(l)-C(2)-C(3)

2.5(3)

C(1 )-C(2)-C(3)-C(4)

0.4(3)

C(2)-C(3)-C(4)-C(5)

-3.4(3)

C(2)-C(3)-C(4)-C(6)

-179.24(18)

C(l)-N(l)-C(5)-C(4)

-1.2(3)

C(l)-N(l)-C(5)-C(5)#2

178.4(2)

C(3)-C(4)-C(5)-N(l)

3.9(3)

C(6)-C(4)-C(5)-N( 1)

179.85(17)

C(3)-C(4)-C(5)-C(5)#2

-175.7(2)

C(6)-C(4)-C(5)-C(5)#2

0.3(3)

C(7)-N(2)-C(6)-C(4)

-164.63(15)

C(7)-N(2)-C(6)-C(6)#2

72.13(16)

C(5)-C(4)-C(6)-N(2)

-90.98(19)

C(3)-C(4)-C(6)-N(2)

84.8(2)

C(5)-C(4)-C(6)-C(6)#2

34.7(2)

C(3)-C(4)-C(6)-C(6)#2

-149.50(19)

C(6)-N(2)-C(7)-C(9)

61.7(3)

C(6)-N(2)-C(7)-C(8)

-171.99(16)
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C(6)-N(2)-C(7)-C(9A)

68.5(2)

N(2)-C(7)-C(9)-C( 14)

64.1(7)

C(8)-C(7)-C(9)-C(14)

-60.6(8)

C(9A)-C(7)-C(9)-C(14)

23.7(10)

N(2)-C(7)-C(9)-C( 10)

-124.6(3)

C(8)-C(7)-C(9)-C( 10)

110.82(15)

C(9A)-C(7)-C(9)-C( 10)

-164.9(10)

C(14)-C(9)-C(10)-C(l 1)

-10.5(7)

C(7)-C(9)-C(10)-C(l 1)

177.6(5)

C(9)-C(10)-C(l 1)-C(12)

7.7(10)

C(10)-C(l 1)-C(12)-C(13)

-1.8(17)

C(11)-C(12)-C(13)-C(14)

-0.8(19)

C(10)-C(9)-C(14)-C(13)

7.3(13)

C(7)-C(9)-C( 14)-C( 13)

178.9(8)

C( 12)-C( 13)-C( 14)-C(9)

-2.1(17)

N(2)-C(7)-C(9 A)-C( 10A)

-145.2(4)

C(9)-C(7)-C(9A)-C( 10A)

-2.9(9)

C(8)-C(7)-C(9A)-C( 10A)

96.5(4)

N(2)-C(7)-C(9A)-C( 14A)

39.8(4)

C(9)-C(7)-C(9 A)-C( 14A)

-177.9(12)

C(8)-C(7)-C(9A)-C( 14A)

-78.4(4)

C(14A)-C(9A)-C(10A)-C(11A)

-0 .6 (8 )

C(7)-C(9A)-C( 10A)-C( 11A)

-175.9(5)
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C(9A)-C( 10A)-C( 11A)-C(12A)

1.7(10)

C( 10A)-C( 11A)-C( 12A)-C( 13A)

-1.4(9)

C(11A)-C(12A)-C(13A)-C(14A)

0

. 1 (8 )

C( 10A)-C(9A)-C( 14A)-C( 13A)

-0 .8 (6 )

C(7)-C(9A)-C( 14A)-C( 13A)

174.5(3)
1.0(7)

C(12A)-C( 13A)-C( 14A)-C(9A)

Symmetry transformations used to generate equivalent atoms:
#1

-x+2 ,-y+0 ,z+ 0

# 2

-x+2 ,-y+l,z + 0

Me

Me

(5 S ,6 S )-5 , 6-Dihydro-A5^V6-bis((if)-l-phenylethyl)-l,10-phenanthroline-5,6-diamine

Yellow foam solid (m.p. 62 °C). *H NMR (400 MHz, CHC13) 5 d 8.776 (2H, d, J = 3.66
Hz), 7.331-7.191 (14H, m), 3.693 (2H, s), 3.587 (2H, q, J = 6.59, 6.59 Hz), 1.021 (3H, d,
J = 6.59 Hz); 13C NMR (100 MHz, CDC13) 5 d 150.3, 150.1, 145.2, 137.8, 133.3, 129.1,
128.8, 128.5, 127.1, 126.8, 123.5, 58.1, 55.5, 25.7; FT-IR (NaCl-DCM solution) v/cnf 1
3238, 3057, 3025, 2964, 2925, 2861, 1602, 1578, 1561, 1491, 1450, 1425, 1367, 1267,
1212, 1124, 1081, 1060, 812, 757, 737, 702; [a]D = +23.7°.
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G en era l m e th o d f o r th e p rep a ra tio n o f C 2 a n d 5 ,6 -o x a zo lid in o n e -l,1 0 -p h e n a n th ro lin e P d co m p le xes

1,10-Phenanthroline ligand (1.0 eq.) was added to an equimolar solution of
Pd(MeCN)2 Cl2 in DCM (anhydrous). The mixture was stirred overnight at 30°C. The
yellow precipitate was collected by filtration, washed with cold DCM and dried in a
vacuum oven at 50° for 6 hrs.
Me

Me

Pd

CP "Cl

(5i?,6i?)-5,6Dihydro-/V5,/V6-bis((i?)-l-phenylethyl)-l,10-phenanthroline-5,6-diaminePdCl2 complex, (C 2(R R R R )-P d C l2)
'H NMR (400 MHz, DMSO_D6) 5 8.81 (2H, d, J = 5.13 Hz), 7.81 (2H, d, J = 7.69 Hz),
7.62 (2H, t, J = 6.22, 6.59 Hz), 7.19-7.34 (10H, m), 4.01 (2H, broad s), 3.70 (2H, broad
s), 2.71 (2H, broad s), 1.08 (6 H, d, J = 5.86 Hz); 13C NMR (100MHz, DMSO_D6) 5
153.5, 148.0, 146.3, 142.0, 137.9, 128.9, 127.3, 127.1, 56.3, 55.7, 25.1.
Me

Me

Pd

CP Cl
(55',65')-5,6Dihydro-N5^V6-bis((i?)-l-phenylethyl)-l,10-phenanthroline-5,6-diaminePdCl2 complex, (C 2(R S S R )-P d C l2)
’H NMR (400 MHz, DMSO_D6)

8

8.90 (2H, t, J = 3.30, 3.30 Hz), 7.71 (4H, d, J = 3.66

Hz), 7.29-7.35 (6 H, m), 7.17(4H, d, J = 6.60 Hz), 3.65 (2H, d, J = 8.79 Hz), 3.48 (2H,
appear q, J = 3.30, 6.22 Hz), 2.68 (2H, dd, J = 2.93, 8.79 Hz), 0.96 ( 6 H, d, J = 6.22 Hz).
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— N.

,N —
Pd

Cl'

Cl

3-(4-Ethylphenyl)-3,3a-dihydrooxazoIo[5,4-f|[l,10]phenanthrolin-2(llbH)-one
complex

Pd

!H NMR (400 MHz, DMSO_D6) 5 8.80 (1H, d, J = 5.49 Hz), 8.74 (1H, d, J = 5.49 Hz),
8.40 (1H, d, J = 7.69 Hz), 7.88 (1H, t, J = 6.22, 6.96 Hz), 7.66 (1H, t, J = 6.59, 6.59 Hz),
7.45 (1H, d, J = 7.69 Hz), 7.33-7.37 (4H, m), 6.15 (1H, d, J = 14.65 Hz), 6.02 (1H, d, J =
14.65 Hz), 2.67(2H, q, J = 7.69, 7.69, 7.32 Hz), 1.23 (3H, t, J = 7.69, 7.32 Hz); 13C NMR
(100MHz, DMSO_D6)

8

157.3, 154.2, 153.3, 148.7, 148.1, 143.0, 135.6, 135.5, 135.3,

133.6, 133.3, 129.3, 128.3, 127.7, 123.7, 75.1, 59.4, 28.2, 16.0; (m.p. >250°C).

OMe

— N.

.N —
Pd

Cl'

Cl

3-(4-Methoxybenzyl)-3,3a-dihydrooxazolo[5,4-f][l,10]phenanthrolin-2(llbH)-one
Pd complex
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*H NMR (400 MHz, DMSOJDg)

8

8.76 (2H, t, J = 6.59, 6.22 Hz), 8.44 (1H, d, J = 7.69

Hz), 8.27 (1H, d, J = 7.69 Hz), 7.79 (2H, dd, J = 8.06, 8.44 Hz), 7.29 (2H, d, J = 8.79
Hz), 6.90 (2H, d, J = 8.42 Hz), 5.88 (1H, d, J = 14.65 Hz), 5.04 (1H, d, J = 14.65 Hz),
4.77-4.92 (2H, ABqt, J = 15.38, 15.74 Hz); 13C NMR (100MHz, DMSO_D6) 5 159.8,
159.6, 154.1, 153.3, 148.4, 148.1, 135.8, 134.8, 133.6, 133.3, 130.1, 128.1, 127.7, 127.5,
114.9, 74.9, 59.2, 55.6, 48.2; FT-IR (KBr) v/cm ' 1 3096, 2837, 1780, 1610, 1513, 1428,
1379, 1248, 1178, 1155, 1110, 1044, 968, 898, 807, 728, 563; m.p. > 250°C

G en era l m e th o d f o r th e p rep a ra tio n o f 5 ,6 -o x a zo lid in o n e -l,1 0 -p h e n a n th ro lin e -Z n
co m p lexes

The oxazolidinone ligand (1.0 equiv) was mixed with an equimolar solution of
anhydrous ZnCh in dry MeOH. The mixture was stirred under argon at room temperature
overnight. Solvent evaporation yielded the complex.
OM e

3-(4-Methoxybenzyl)-3,3a-dihydrooxazolo[5,4-f][l,10]phenanthrolin-2(llbH)-oneZn complex
'H NMR (400 MHz, CHC13)

6

d 8.83 (2H, d, J = 5.13 Hz), 8.21 (2H, dd, J = 7.69, 8.06

Hz), 7.81 (2H, ddd, J = 5.49, 8.06 Hz), 7.21 (2H, d, J = 8.42 Hz), 6.85 (2H, d, J = 8.79
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Hz), 5.41 (lH,d, J = 14.28 Hz), 5.11 (1H, d, J = 15.01 Hz), 4.61 (2H, dd, J = 15.38, 14.28
Hz), 3.75 (3H, s); 13C NMR (100 MHz, CDC13)

8

d 160.2, 159.1, 149.0, 148.5, 145.3,

144.4, 135.4 135.1, 133.0, 132.3, 129.7, 128.2, 127.8, 125.4,115.0, 74.2, 59.1, 55.4, 49.6.

G en era l m e th o d f o r p re p a ra tio n o f co m p le xes [(L )-l,3 -r f-p r o p e n y l)P d ] CF3SO3.

To chloroform (3 mL) (1.0 equiv) allylpalladium chloride dimer and (1.1 equiv) silver
trifluromethansulfonate was added. The mixture was stirred for 10 min at room
temperature under argon atmosphere, and then an equimolar amount o f nitroligand was
added. After a further 30 min the mixture was filtered and diethyl ether added to initiate
the crystallization, followed by storage at -10°C.
OM e

HO

HN

OTf

(1,3-r)3-

5,6-Dihydro-6-(4-methoxybenzylamino)-l,10-phenanthrolin-5-ol
propenyl)Pd trifluoromethanesulfonate complex

Recrystalization in CHCh/ether yielded yellow solid (m.p. 148°C). !H NMR (400 MHz,
DMSO) 5 8.87 (2H, dd, J = 5.49, 6.22 Hz), 8.27 (1H, d, J = 8.06 Hz), 8.22 (1H, d, J =
7.69 Hz), 7.78 (2H, ddd, J = 7.69, 5.49 Hz), 7.22 (2H, d, J = 7.69 Hz),

6 .8 6

(2H, d, J =

7.32 Hz), 6.07 (1H, tt, J = 10.25, 9.52 Hz), 5.99 (1H, d, J = 4.76 Hz), 5.03 (1H, s), 4.50
(2H, d, J = 6.22 Hz), 4.09 (1H, d, J = 3.28 Hz), 3.70 (3H, s), 3.64 (2H, s) 3.56 (2H, d, J =
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11.72 Hz); 13C NMR (100 MHz, DMSO)

6

158.7, 153.3, 152.9, 151.2, 151.1, 141.4,

141.3, 138.1, 137.4, 132.7, 129.7, 128.5, 128.1, 122.9, 120.3, 119.7, 114.1, 69.2, 63.1,
60.2, 55.6, 49.9; Anal Calcd for C 2 4 H2 3 F3 N 3 0 5 PdS: C, 45.83; H, 3.69; N, 6 .6 8 ; S, 5.10.
Found C, 45.83; H, 3.73; N, 6.58; S, 4.77.

OMe

5,6-Oxazolidinone-6-A-(4-methoxybenzylamino)-l,10-phenanthrolin-5-ol
propenyl)Pd trifluoromethanesulfonate complex

(1 ,3 -rj3-

*H NMR (400 MHz, CDC13) 5 8.78 (2H, dd, J = 5.13, 5.49 Hz), 8.21 (1H, d, J = 7.69 Hz),
8.13 (1H, d, J = 7.69 Hz), 7.76 (2H, ddd, J = 8.06, 5.49 Hz), 7.23 (2H, d, J = 8.42 Hz),
6.80 (2H, d, J = 8.79 Hz), 5.92 (1H, m), 5.45 (1H, d, J = 14.65 Hz), 4.97 (1H, d, J = 15.74
Hz), 4.68 (2H, d, J = 15.38 Hz), 4.40 (2H, app t, J = 3.30, 5.86 Hz), 3.71 (3H, s), 3.55
(1H, d, J = 12.81 Hz); 13C NMR (100 MHz, CDC13) 5 159.8, 159.5, 153.1, 153.0, 150.8,
150.3, 135.1, 134.1, 133.4, 133.0, 129.7, 128.6, 128.4, 126.2, 122.4, 119.9, 114.7, 74.5,
63.2, 59.7,55.4, 49.1.

141

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(5R , 6i?)-5,6-Dihydro-Ar5r/V6-bis((/?)-l-phenylethyl)-l,10-phenanthroline-5,6-diamine

(l,3-ri3-propenyl)Pd trifluoromethanesulfonate complex
Recrystalization in CHCb/ether yielded yellow needle (m.p. 62°C). 'H NMR (400 MHz,
DMSO) 5 8.77 (2H, d, J = 4.76 Hz), 7.82 (2H, d, J = 7.69 Hz), 7.61 (2H, t, J = 5.49, 6.96
Hz), 7.30 (4H, t, J = 6.96, 7.32 Hz), 7.23 (2H, t, J 6.96, 7.32 Hz), 7.17 (4H, d, J = 7.32
Hz), 6.06 (1H, m), 4.46 (2H, d, J = 5.86 Hz), 4.06 (2H, d, J=4.76 Hz), 3.69 (2H, appt, J =
6.22, 5.49 Hz), 3.52 (2H, appt, J = 12.08, 11.72 Hz), 2.62 (2H, s), 1.08 (6 H, d J = 6.96
Hz).

CH(C02Me)2
P h '^ ^ P h
G en era l p r o c e d u re f o r allylic a lkyla tio n re a c tio n : dimethyl 2-((E)-l,3-diphenylallyl)

malonate
A solution of the ligand (0.08 mmol, 10 mol %) and [Pd(r|3 -C3 H 5 )C 1 ] 2

(8

mg, 2.5 mol%)

in dry CH2 CI2 ( 2mL) was stirred at room temperature for 30 min. To this solution was
added a solution of rac-(E)-l,3-diphenyl-2-propenyl acetate (200 mg, 0.79 mmol) in dry
CH2 CI2 (1 mL), dimethyl malonate (316 mg, 2.4 mmol), A,0-bis(trimethylsilyl)acetamide (BSA) (488 mg, 2.4 mmol) and sodium acetate (2.4 mg, 3.5 mol%). The
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reaction mixture was stirred overnight until conversion was complete (monitored by
TLC, SiCh, petroleum/ether 3:1), diluted with ether (25 mL), and washed with cold
saturated NH 4 CI. The organic phase was dried over Na2 SC>4 and concentrated in vacuo.
The residue was purified by flash chromatography, SiC>2 , petroleum/ether (3:1), to yield
l,3-diphenylprop-2-enylmalonate. The enantiomeric excess was determined by 'H NMR
in the presence of enantiomerically pure shift reagent, (Eu(hfc)3 . Splitting of the signals
for one of the two methoxy groups was observed. Chiral HPLC was also performed with
Daicel OD-H 25x0.46 cm (L x I.D.) at X = 254 nm; flow rate 0.5 mL/min; eluent :
Hexanes/IPA (200:1), t* = 23.5 min

25.0 min. *H NMR (400 MHz, CDC13) 5 7.18-

7.33 (10H, m), 6.5 (1H, d, J = 15.74 Hz), 6.36 (1H, dd, J = 15.74, 8.79 Hz), 4.29 (1H, dd,
J = 10.98, 10.62 Hz), 3.98 (1H, d, J = 10.98 Hz), 3.71 (3H, s), 3.52 (3H, s).

OH

G en era l p ro c e d u re f o r R e d u c tio n o f a c e to p h e n o n e rea c tio n : 1-phenylethanol

In a small flask, ZnEt2 (0.014 mL, 1M in heptane, 0.083 mmol) and chiral ligand (0.083
mmol) in 1 mL of freshly distilled toluene were stirred under argon at room temperature
for 10 min. Then (0.20 g, 1.66 mmol) acetophenone, and (EtO^SiH were added slowly to
the mixture. The reaction was stirred for 18-24 h. The solvent was removed by rotavap
and the residue was purified by SiC>2 gel column with hexanes/EtOAc (10:1) as eluent.
The silano product was dissolved in a small amount of MeOH, followed by the addition
of KF aqueous solution and stirred for 2 hrs. This mixture was extracted with CHCI3 ,
dried over Na2 SC>4 , filtered and evaporated to give the alcohol product as a colorless
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liquid. lH NMR (400 MHz, CDCI3 )

8

7.27-7.36 (5H, m), 4.87 (1H, q, J = 6.59, 6.22 Hz),

2.00(1H, s), 1.50 (3H, d, J = 6.22 Hz). The enantiomeric excess was determined from
chiral HPLC Daicel OD-H 25x0.46 cm (L x I.D.) at X = 254 nm; flow rate 0.5 mL/min;
eluent: Hexanes/IPA (95:5),

= 16.3 min ts= 19.3 min; Reference (R)-l-phenylthanol t«

= 16.7 min.

OH

O

G eneral p r o c e d u re f o r d irect aldol: 4-Hydroxy-4-(4-nitrophenyl)butan-2-one

To a solution of the ligand (0.2 equiv.) in MeOH (0.1M with respect to the aldehyde) at
room temperature was added Zn(NC>3 .6 H2 0 (0.1 equiv.). To the complex was then added
p-nitrobenzaldehyde

(1

equiv.), distilled acetone

(2 0

equiv.) and small amount of Et3N.

The resulting solution was then stirred under argon atmosphere for 2 days. The crude
mixture solvent was concentrated and the residue purified by column chromatography of
(SiC>2 , Hexanes/EtOAc 3:1) to afford the aldol product in 76% yield. *H NMR (400 MHz,
CDCI3 )

8

8.16 (2H, d, J = 8.79 Hz), 7.52 (2H, d, J = 8.42 Hz), 5.22-5.26 (1H, m), 3.67

(1H, d, J = 3.30 Hz), 2.85 (1H, s), 2.83 (1H, d, J = 2.20 Hz), 2.22 (3H, s); 13C NMR (100
MHz, CDCI3 )

8

208.6, 150.1, 147.3, 126.5, 123.8, 69.0, 51.6, 30.8; FT-IR (NaCl-DCM

solution) v/cm' 1 3432, 3112, 3080 3003, 2915, 1713, 1604, 1519, 1348, 1164, 1076, 857,
749, 698, 536.
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o

G en era l

p ro c e d u r e

fo r

M ic h a e l

addition

Ethyl

p ro d u ct:

o

2-oxo-l-(3-

oxobutyl)cyclohexanecarboxylate
Ni(0ac)2 . 4 H 2 O (7.3 mg, 0.05 equiv.) was added to a solution of C2 ORRRR) (25.0 mg,
0.10 equiv.) in CHCI3 (1.0 mL/mmol ethyl 2-oxocyclohexanecarboxylate) and the
mixture

was

stirred

at

oxocyclohexanecarboxylate

room

(1 0 0

mg,

temperature
1 .0

for

1

hr.

Then

ethyl

2-

equiv.) was added, and after further stirring for

2 h, MVK (62 mg, 1.50 equiv.) was added. The resulting solution was stirred for
additional 18 h. All volatile materials were removed in vacuo, and the residue was
purified on SiC>2 (PE/MTB 1:1) to yield a colorless oil product (60%). ‘H NMR (400
MHz, CDCI3 ) 5 4.15-24.23 (2H, m), 2.31-2.61(3H, m), 2.10 (3H, s); 13C NMR (100
MHz, CDCI3 ) 5 208.1, 207.9, 172.1, 61.5, 60.0, 41.1, 38.9, 36.8, 30.0, 28.5, 27.6, 22.6,
14.2; FT-IR (NaCl-DCM solution) v/cm' 1 2940, 2868, 1716, 1559, 1540, 1489, 1419,
1364, 1245, 1188, 1136, 1021,

Cl

6 6 8

.

O

Ph

OM e
NHTs

fraws-Methyl 3-chloro-3-phenyl-2-(tosylamino)propanoate
Solution of fS(1S)-oxa-a(+) ligand (0.014 g, 10 mol%) and allylpalladium chloride dimer
(0.004 g, 2.5 mol%) in dry DCM (2 mL) was stirred under argon atmosphere at room
temperature for 30 min. A pre-dissolved solution of methyl cinanamate (0.065g, 0.4
mmol) and di-chloramine T (0.115g, 0.48 mmol) in dry DCM (2 mL) was added to the
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palladium-ligand solution. The resulting mixture was stirred at room temperature and was
eventually quenched by slowly adding aqueous Na2 SC>3 (4 mL). The layers were
separated and the aqueous layer was extracted with DCM ( 2 x 5 mL). The combined
organic layers were washed with NH 4 C1 solution (10 %), and brine, and dried over
anhydrous MgSC>4 . Finally the solution was filtered, concentrated and purified on SiC>2
(hexanes/EtOAc 3:1) to yield a white solid product (38%). 'H NMR (400 MHz, DMSO)
5 8.76 (2H, d, J = 9.88 Hz), 7.27-7.43 (9H, m), 5.07 (1H, d, J = 10.25 Hz), 4.30 (1H, t, J
= 10.25, 9.89 Hz), 3.37 (3H, s), 2.25 (3H, s); 13C NMR (100 MHz, DMSO) 5 169.9,
143.4, 137.9, 137.3, 129.9, 129.5, 129.1, 128.7, 126.9, 61.7, 60.6, 52.6, 21.5. The
enantiomeric excess was determined by chiral HPLC with Daicel OD-H 25x0.46 cm (L x
I.D.) at X = 254 nm; flow rate 0.5 mL/min; eluent: Hexanes/IPA (95:5), two peaks came
out at 34.2 and 49.6 min.
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Appendix B
C ft NMR, 13C NM R and IR Spectral)
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#
1

Name

Structure

Formular

1,10-phenanthroline-5,6epoxide
P hen-epoxide

O

Ci2 H 8 N20

Mol.
Wt.
196.20

Ci4H12N20

224.26

Ci 8H 15N30

289.33

C 19 H 17N 3 O

303.36

C 18Hi4 BrN30

368.23

C 18 H 1 4 C1N30

323.78

Ci9 Hi4N40

314.34

\= N
2

N =/

O

.9-dimethyl-1 , 1 0 phenanthroline-5,6 -epoxide
2.9-Phen-epoxide
2

N =(

Me
3

trans-5,6-dihydro-6anilylamino-1 , 1 0 phenanthroline-5-ol
anilyl-L

4

trans-5,6-dihydro-6benzylamino-1 , 1 0 phenanthroline-5-ol
benzyl-L

Me

H
vrO
\= N

N=/

jP
HO HN—'

0—
0
\= N

5

trans-5,6-dihydro-6-(2bromo-anilylamino)-1 , 1 0 phenanthroline-5-ol
2-Br-anilyl-L

N=/

no H N - ^ )

OH
\= N

6

N =/

trans-5,6-dihydro-6-(2chloro-anilylamino)-1 , 1 0 phenanthroline-5-ol
2-Cl-anilyl-L

0—
0
^=N

7

trans-5,6-dihydro-6-(2cyano-anilylamino)-1 , 1 0 phenanthroline-5-ol
2-CN-aniIyl-L

N =/
NC

HO HN—

0—
0
^=N

N = /
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8

Et

trans-5,6-dihydro-6-(2ethyl-anilylamino)-1 , 1 0 phenanthroline-5-ol
2-Et-anilyl-L

trans-5,6-dihydro-6-(4ethyl-anilylamino)-1 , 1 0 phenanthroline- 5-ol
4-Et-anilyl-L

(

r

-

trans-5,6 -dihydro-6 -azido1,10-phenanthroline-5-ol
azido ale.

k

317.38

Ci2 H9 N50

239.23

C 17 H 14 N 4 O

290.32

OMe

C2 2 H2 3 N 3 O2

361.44

OMe

C2 2 H2 1 NO 2

331.41

^ —Et

S

N=/

HO

^=N
11

C2 0 H 19N 3 O

N =/

HO HN—^

\= N

10

317.38

HQ

^=N
9

C2 0 H 19N 3 O

N3

N=/

Q

5,6 -dihydro-6 -(pyridin-2 ylamino)-l,1 0 phenanthrolin-5-ol

HO

NH

FS L
\= N
12

6-(4methoxybenzylamino)-5,6dihydro-2 ,9-dimethyl-1 , 1 0 phenanthrolin-5-ol
2,9-diMe-(4-MeObenzyl)-L

N =/

P

HN— '

HO

)= N

N=(

h 3c

13

trans-6-(4-Methoxybenzy lamino)-5,6 -dihydro1,10-phenanthroline-5-ol
(+)-4-MeO-benzyl-L

HO

ch3

P

HN-7
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14

15

16

17

trans-6-(4-Methoxybenzy lamino)-5,6-dihydro1,10-phenanthroline-5-ol
(-)-4-MeO-benzyl-L

trans-(5R,6R)-6-((R)-lphenylethylamino-5,6dihydro-1,10phenanthroline-5 -ol
(R,R)-a(+)-L
trans-(5 S,6S)-6-((R)-1phenylethylamino-5,6dihydro-1,10phenanthroline-5-ol
(S,S)-a(+)-L

OMe

HQ

CH3
ho

h n

\= N

317.38

C2oHi9N30

317.38

c 22h 23n 3o

345.44

c 21h

17n 3o 2

343.38

C2iH 17N30 2

343.38

N = /
ch

HQ

3

H N -Q

'r—t

'= N

^Ph

N = /

<s h 3
HO

HN—(

) —\
)= N

19

C20Hi9N3O

- ^

} --- ; ' ^Ph
,__ /(R)<r\ __ s
f y _ A

6-((R)-lphenylethylamino)-5,6dihydro-2,9-dimethyl-1,10phenanthrolin-5-ol
2,9-diMe-a(+)-L

(3aS,l lbS)-3,3a-dihydro3-((R)-lphenylethyl)oxazolo[5,4f] [ 1,10]phenanthrolin2(1 lbH)-one
(S,S)-oxa-a(+)
(3aR,l lbR)-3,3a-dihydro3-((R)-lpheny lethy l)oxazolo [5,4f] [ 1,10]phenanthrolin2(llbH)-one
(R,R)-oxa-a(+)

331.41

HN—'

Ph
N=(

h 3c

18

C22H21N02

ch3

J

PH,

(S))—

, NT i Ph
(

9

\= N

N =/
8

P H3

(R))--- ;
™
,__ / (Rh__ ,
A
_ A
\= N
N =/
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20

3-(4-methoxybenzy l)-3,3 adihydrooxazolo [5,4f][l, 1O]phenanthrolin2(llbH)-one
(+)-oxa-4-MeO

21

3-(4-methoxybenzy l)-3,3 adihydrooxazolo[5,4f] [ 1,10]phenanthrolin2(llbH)-one
(-)-oxa-4-MeO

c 21h 17n 3o 3

359.38

OMe

C2iH 17N30 3

359.38

c 20h 15n 3o 2

329.35

C2iH i7N30 2

343.38

C2oH i7N3

299.37

C28H28N4

420.55

-6
°
A
/yK
\= N

N =/

.6
\= N

22

OMe

(3aR,llbR)-3-benzyl-3,3adihydrooxazolo[5,4f] [ 1,10]phenanthrolin2(1 lbH)-one
oxa-benzyl

N =/

O

o

° M
\= N

23

3-(4-ethylphenyl)-3,3adihydrooxazolo[5,4f] [ 1,10]phenanthrolin2(llbH)-one
oxa-4-Et-anilyl

24

(1 aS,9bR)-1a,9b-dihydro1-((R)-1-phenylethyl)-1Hazirino[2,3f] [ 1,10]phenanthrol-ine
a(+)-aziridine

J-rOT
\= N

25

(5R,6R)-5,6-dihydroN5,N6-bis((R)-lphenylethyl)-l,10phenanthroline-5,6diamine
C 2 (RRRR)

N =/
H3 C,,^Ph
N

\= N
N =/
Me
Me
1 -n h
m -C
PH(R) )—
(R>Ph

\= N

N =/
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26

27

28

29

30

(5S,6S)-5,6-dihydroN5,N6-bis((R)-lphenylethyl)-l,10phenanthroline-5,6diamine
C2 (RSSR)
(5R,6R)-5,6-dihydroN5,N6-bis((R)-lphenylethyl)-l,10phenanthroline-5,6diamine-PdCl2 complex
C2 (RRRR)-PdCI2

Me
Me
h -H H h n - x
P t i (R>
(R^ P h
J___ / S)( s \ ___
\= N

3-(4-ethylphenyl)-3,3adihydrooxazolo[5,4f] [ 1,1 Ojphenanthrolin2(llbH)-one PdCl2
complex
oxa-4-Et-anilyl-PdCl2
3,3 a-dihydro-3 -((R)-1phenylethyl)oxazolo[5,4f] [ 1,1 OJphenanthrolin2(1 lbH)-one-PdCl2
complex
oxa-a(+)-PdCl2

420.55

c 28h 28c i 2n 4p

597.87

c 28h 28c i 2n 4p

597.87

C2iH17C12N30
2Pd

520.70

C2iH i7C12N30
2Pd

520.7

C2iH 17C12N30
3Pd

536.70

N = /

Me

Me
> r-N H H N - ^
Ph/(R) W
<R>Ph
____/ r>(r)\___ ,
f y - f A
\ = N S XN = /
Pd
C l7 ‘Cl
Me
Me
V - N H HN—^
P h rRj
fR/Ph
____/ S)( s \ ___

(5S,6S)-5,6-dihydroN5,N6-bis((R)-lphenylethyl)-l,10phenanthroline-5,6diamine-PdCl2 complex
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3-(4-methoxybenzy l)-3,3 adihydrooxazolo[5,4f] [ 1,10]phenanthrolin2(1 lbH)-one Pd complex
oxa-4-MeO-PdCl2
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3-(4-methoxybenzyl)-3,3adihydrooxazolo[5,4f] [ 1 , 1 0 ]phenanthrolin2(1 lbH)-one-Zn complex
oxa-4 -MeO-ZnCl2
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5,6-dihydro-6-(4methoxybenzylamino)1,10-phenanthrolin-5-ol
(1,3 -il 3-propeny l)Pd
trifluoromethanesulfonate
complex
4-MeO-benzyl-Pd-OTf
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trifluoromethanesulfonate
complex
oxa-4-MeO-Pd-OT f
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(5R,6R)-5,6-dihydroN5,N6-bis((R)-lphenylethyl)-l,1 0 phenanthroline-5,6 diamine-(l,3-r|3propenyl)Pd
trifluoromethanesulfonate
complex
C 2 (RRRR)-Pd-OTf
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